Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
   volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             2578 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Aβ accumulation correlates with cognitive decline: results from the longitudinal AIBL study Villemagne, Victor
2011
7 4S p. S427-
1 p.
artikel
2 Aβ accumulation correlates with cognitive decline: results from the longitudinal AIBL study Villemagne, Victor
2011
7 4S p. S39-
1 p.
artikel
3 AATF activates an extrinsic pathway of neurodegeneration Guo, Qing
2011
7 4S p. S386-
1 p.
artikel
4 AAV gene therapy with cholesterol 24-hydroxylase improves Alzheimer's phenotype of tau mouse model Cartier, Nathalie
2011
7 4S p. S651-
1 p.
artikel
5 ABCA1 deficiency decreases Amyloid clearance and increases Amyloid aggregation in Alzheimer's disease mouse model Fitz, Nicholas
2011
7 4S p. S702-S703
2 p.
artikel
6 Aberrant Microglial Activation Contributes To Cognitive Deficits In Alzheimer’s Disease Gan, Li
2011
7 4S p. S286-S287
2 p.
artikel
7 Abeta 1-42 binding to red blood cells: A potential marker for Alzheimer's disease de Barry, Jean
2011
7 4S p. S134-
1 p.
artikel
8 Abeta dimers mediate plaque-associated cytopathology without affecting cognition Liu, Peng
2011
7 4S p. e23-
1 p.
artikel
9 Abeta systems pharmacology: An initial model for wild type mouse, monkey, and human Barton, Hugh
2011
7 4S p. e15-
1 p.
artikel
10 A blood-based predictor for neocortical amyloid load in Alzheimer's disease Burnham, Samantha
2011
7 4S p. e12-
1 p.
artikel
11 A blood gene expression biomarker of early Alzheimer's disease Hodges, Angela
2011
7 4S p. e13-e14
nvt p.
artikel
12 Aβ blood levels and Alzheimer's disease. Pesini, Pedro
2011
7 4S p. S325-S326
2 p.
artikel
13 Abnormal brain metals concentration in Alzheimer's disease Leite, Renata
2011
7 4S p. S704-
1 p.
artikel
14 Abnormal CDK11/PITSLRE cell cycle dynamics mediated by app: relevance to Alzheimer's disease Su, Bo
2011
7 4S p. S405-
1 p.
artikel
15 Abnormal connectivity of the hippocampus in amnestic mild cognitive impairment: A diffusion tensor tractography study Zhuang, Lin
2011
7 4S p. S748-
1 p.
artikel
16 Abnormalities in localized and long-range functional connectivity of resting-state sub-networks in patients with mild cognitive impairment and Alzheimer's disease Wong, Christina
2011
7 4S p. S747-
1 p.
artikel
17 About correlation between the simple cognitive test and the Frontal Assessment Battery Nagata, Hirokazu
2011
7 4S p. S257-
1 p.
artikel
18 A brain computer interface to detect Alzheimer's disease Simon, Adam J.
2011
7 4S p. S145-S146
2 p.
artikel
19 A candidate causal variant in the CR1 locus Keenan, Brendan
2011
7 4S p. S496-S497
2 p.
artikel
20 A candidate genes study of structural and functional brain aging in the Baltimore Longitudinal Study of Aging Driscoll, Ira
2011
7 4S p. S232-
1 p.
artikel
21 Acceleration of brain atrophy rates with advancing cognitive deterioration from normal aging to MCI to Alzheimer's disease Schuff, Norbert
2011
7 4S p. S223-
1 p.
artikel
22 Accuracy of ß-amyloid PET with florbetaben in Alzheimer's disease (AD) patients and healthy volunteers (HVs): influence of scan duration Osama, Sabri
2011
7 4S p. e70-e71
nvt p.
artikel
23 Accurate non-invasive diagnoses of Alzheimer's disease using eye scanning Bandelow, Stephan
2011
7 4S p. S155-S156
2 p.
artikel
24 Acetylation of tau contributes to tau accumulation and dysfunction Gan, Li
2011
7 4S p. S689-
1 p.
artikel
25 Acetylcholinesterase expression levels modulates Presenilin-1 Garcia-Ayllon, Maria-Salud
2011
7 4S p. S410-
1 p.
artikel
26 A community-based study of the Montreal Cognitive Assessment (MoCA) in Japan: The Kurihara Project Kasai, Mari
2011
7 4S p. S249-
1 p.
artikel
27 A Compact and structured representation of the rate of brain tissue deformation Veerman, Jan
2011
7 4S p. S727-
1 p.
artikel
28 A comparative study of voxel and surface-based cortical thickness methods in frontotemporal dementia Clarkson, Matthew
2011
7 4S p. S56-
1 p.
artikel
29 A comparison of conventional versus push-pull microdialysis for the detection of amyloid β in the mouse brain Motter, Ruth
2011
7 4S p. S120-
1 p.
artikel
30 A Comparison of Executive Functions in MCI And Alzheimer’s Patients Pakzad, Sarah
2011
7 4S p. e72-
1 p.
artikel
31 A comparison of F-18 FDG-PET imaging in differential diagnosis of Alzheimer's disease and dementia with Lewy body disease Jang, Eun Hye
2011
7 4S p. S339-
1 p.
artikel
32 A comparison of MRI derived vascular burden and hippocampal volumes in healthy ageing and Alzheimer's disease Murray, Alison
2011
7 4S p. S423-S424
2 p.
artikel
33 A comparison of the diagnostic sensitivity for Alzheimer's disease among MRI, ECD-SPECT, FDG-PET, and cerebrospinal fluid biomarkers in a memory clinic Morinaga, Akiyoshi
2011
7 4S p. S163-
1 p.
artikel
34 A confirmatory phase 3 randomized, double-blind, placebo-controlled study of the safety and effectiveness of immune globulin intravenous (Human), 10% solution (GAMMAGARD LIQUID/KIOVIG) for the treatment of mild to moderate Alzheimer's disease: Lee, Deborah A.
2011
7 4S p. S783-S784
2 p.
artikel
35 Acting is the Key: New directions for the stimulation of prospective memory in mild cognitive impairment Pereira, Antonina
2011
7 4S p. S543-S544
2 p.
artikel
36 Action-intentional spatial bias in a patient with posterior cortical atrophy Kwon, Jay
2011
7 4S p. e44-
1 p.
artikel
37 Activated thalamic glucose metabolism after combined donepezil and psychosocial intervention in Alzheimer's disease: The Osaki-Tajiri project Meguro, Mitsue
2011
7 4S p. S647-
1 p.
artikel
38 Activation of frontal lobe by music therapy in mild cognitive impairment and Alzheimer's disease revealed by FDG-PET Kanemaru, Kazutomi
2011
7 4S p. S655-
1 p.
artikel
39 Activation of nicotinic cholinergic receptors modifies the processing of rat hippocampal amyloid precursor protein both in vivo and in vitro Scerri, Charles
2011
7 4S p. S581-
1 p.
artikel
40 Activation of TLR-4 receptors by Par-4 in neuronal degeneration in Alzheimer's disease Xie, Jun
2011
7 4S p. S380-
1 p.
artikel
41 Active and passive immunotherapy in Htau mice Acker, Christopher
2011
7 4S p. S558-
1 p.
artikel
42 Active immunization against pyroGlu-3 Aβ generates high antibody titers and lowers plaque burden in APP transgenic mice Lemere, Cynthia A
2011
7 4S p. S87-
1 p.
artikel
43 A curcumin analogue as a “smart” fluorescent probe with potential capacity for in vivo imaging the full course of amyloidosis of Alzheimer's disease Ran, Chongzhao
2011
7 4S p. S308-
1 p.
artikel
44 Acute inhibition of gamma secretase lowers abeta dimer levels in plaque-bearing PSAPP mice Needle, Elie
2011
7 4S p. S393-
1 p.
artikel
45 Addenbrooke's cognitive examination-revised and mini mental state examination in patients with different types of cognitive impairment Alves, Luísa
2011
7 4S p. S237-
1 p.
artikel
46 Addressing behaviors of concern in the bush: Non-pharmacological sustainable practice change Davis, Sandra
2011
7 4S p. S629-S630
2 p.
artikel
47 Aß deposition in the nasal cavity of a transgenic mouse model of Alzheimer's disease Kameshima, Naoko
2011
7 4S p. S139-S140
2 p.
artikel
48 Adjustment disorder with anxiety in patients aged more than 60 years old Arbus, Christophe
2011
7 4S p. S372-S373
2 p.
artikel
49 ADL functions and relationship to cognitive status Foldi, Nancy
2011
7 4S p. S244-
1 p.
artikel
50 Administration of 17β estradiol modulates the age related neuronal markers in naturally menopausal rats from different age groups Kumar, Pardeep
2011
7 4S p. S114-S115
2 p.
artikel
51 AD TMT-SRM Assay - delivering simultaneous quantitation of 9 key plasma proteins in clinical cohorts relevant to AD research O'Brien, Darragh
2011
7 4S p. S333-
1 p.
artikel
52 Advance care planning for subjects with early dementia: an Asian perspective Ali, Noorhazlina
2011
7 4S p. S622-S623
2 p.
artikel
53 Advanced directives: Is intensive care unit the setting to introduce them? Navedo, Yerania Rodriguez
2011
7 4S p. S640-
1 p.
artikel
54 Advanced Glycation Endproduct Level, Diabetes and Accelerated Cognitive Aging Yaffe, Kristine
2011
7 4S p. S289-
1 p.
artikel
55 Advances in individually-based imaging biomarkers using multi-parametric pattern classification Davatzikos, Christos
2011
7 4S p. S230-
1 p.
artikel
56 Adverse drug effects in patients with Alzheimer's disease or another dementia: PEIMA study Laroche, Marie-Laure
2011
7 4S p. S803-
1 p.
artikel
57 A french innovative department dedicated to Alzheimer's disease patients Rebillat, Anne-Sophie
2011
7 4S p. S646-
1 p.
artikel
58 Age, APOE e4, and ethnic effect on [C-11]PiB in multinational ADNI studies: direct comparison of J-ADNI, US-ADNI and AIBL data Ishii, Kenji
2011
7 4S p. S233-
1 p.
artikel
59 Age-associated memory impairment is associated with greater rate of longitudinal brain atrophy Lu, Po-Haong
2011
7 4S p. S30-
1 p.
artikel
60 Age-associated memory impairment is associated with greater rate of longitudinal brain atrophy Lu, Po-Haong
2011
7 4S p. S215-S216
2 p.
artikel
61 Age-dependent changes in the gene expression profile of mice over-expressing mutant APP, PS-1 and phosphorylated tau Gatta, Valentina
2011
7 4S p. S582-S583
2 p.
artikel
62 Age-dependent disruption in hippocampal theta oscillation in APP/PS1 mice Hajos, Mihaly
2011
7 4S p. S586-
1 p.
artikel
63 Age, education and cognitive impairment in an autopsy series of subjects with tau-positive neuropathological frontotemporal lobar degeneration in the National Alzheimer's Coordinating Center (NACC) data sets Phillips, Leslie
2011
7 4S p. S760-
1 p.
artikel
64 A Genome-Wide Association Scan for Episodic Memory Decline in Aging Shulman, Joshua
2011
7 4S p. S195-
1 p.
artikel
65 A Genome-Wide Study of Familial Alzheimer’s Disease Supports Additional Candidate Genes: The NIA-LOAD/NCRAD Family Study Lee, Joseph
2011
7 4S p. S189-
1 p.
artikel
66 A genotype risk score based on Type 2 diabetes risk factors is associated with lower risk for Alzheimer's disease in APOE e4 carriers Proitsi, Petroula
2011
7 4S p. e28-e29
nvt p.
artikel
67 Age of dementia onset delayed by bilingualism, but advanced by stroke Alladi, Suvarna
2011
7 4S p. e21-
1 p.
artikel
68 Age related changes in the default mode network are more advanced in Alzheimer's disease Jones, David
2011
7 4S p. S738-
1 p.
artikel
69 Age-related changes in the default mode network are more advanced in Alzheimer's disease Jones, David
2011
7 4S p. S74-S75
2 p.
artikel
70 Age-related changes of the brain white matter and motion onset electrophysiological response associated with processing of visual motion Kavcic, Voyko
2011
7 4S p. S427-S428
2 p.
artikel
71 Age-related changes of the brain white matter associated with electrophysiological and behavioral processing of visual motion Kavcic, Voyko
2011
7 4S p. S428-
1 p.
artikel
72 Age-related differences in Alzheimer-type neuropathology in brains of double and triple transgenic mice Manaye, Kebreten
2011
7 4S p. S522-S523
2 p.
artikel
73 Age-related neural changes associated with memory functioning Chong, Catherine
2011
7 4S p. S67-
1 p.
artikel
74 Age-related nonlinear trajectory of hippocampal shapes across lifespan Qiu, Anqi
2011
7 4S p. S69-S70
2 p.
artikel
75 Aggregation of Aß42 is strongly influenced by Gly33 of the GxxxG motif and an inhibitor peptide which mimics Gly33 substitutions Harmeier, Anja
2011
7 4S p. S381-
1 p.
artikel
76 Aggregation of the endoplasmic reticulum triggered by oligomeric beta-amyloid peptides could initiate autophagy Zhang, Natalie Qishan
2011
7 4S p. S406-
1 p.
artikel
77 Aggressive evaluation, management and monitoring of MCI/dementia syndromes Jacob, April
2011
7 4S p. S672-
1 p.
artikel
78 Aging and genetics in the lemurian primate Microcebus murinus: A useful approach for Alzheimer's disease studies Verdier, Jean-Michel
2011
7 4S p. e76-
1 p.
artikel
79 Aging diminishes neuronal transport in wild-type mice, but not in an accelerated mouse model of Aβ amyloidosis Bertrand, Anne
2011
7 4S p. S8-
1 p.
artikel
80 Aging diminishes neuronal transport in wild-type mice, but not in an accelerated mouse model of Aβ amyloidosis Bertrand, Anne
2011
7 4S p. S306-
1 p.
artikel
81 Aging in place with dementia: the design of a digital tool for environmental modifications Kort, Helianthe
2011
7 4S p. e71-
1 p.
artikel
82 Aging in place with dementia: the design of a digital tool for environmental modifications Kort, Helianthe
2011
7 4S p. S440-S441
2 p.
artikel
83 Agitated behaviors in elderly persons with dementia and the self-efficacy of their caregivers in the illness stage Huang, Huei-Ling
2011
7 4S p. e51-
1 p.
artikel
84 Agitation and Alzheimer's disease Schneider, Lon
2011
7 4S p. S92-
1 p.
artikel
85 Agmatine prevents scopolamine-induced impairment in water maze performance Khales, Golnaz Yadollahi
2011
7 4S p. S773-
1 p.
artikel
86 Agraphia-Alexia: A Rare form of Focal Atrophy of Uncertain Pathology Troussière, Anne-Cécile
2011
7 4S p. S167-S168
2 p.
artikel
87 A high burden of vascular disease increases the risk of mild cognitive impairment: the mayo clinic study of aging. Roberts, Rosebud
2011
7 4S p. S363-
1 p.
artikel
88 A high throughput screen identifies compounds that inhibit Alzheimer's peptide aggregation and reduce toxicity in vitro and in drosophila melanogaster McKoy, Angela
2011
7 4S p. S466-
1 p.
artikel
89 A home-based training program for family caregivers decreases their risk for depression Shyu, Yea-Ing
2011
7 4S p. S434-
1 p.
artikel
90 AICD is preferentially produced from C99 in a gamma-secretase in vitro assay Flammang, Brice
2011
7 4S p. S407-S408
2 p.
artikel
91 Aβ inhibits specific kinesin motors involved in both mitosis and neuronal function; potential implications for neurogenesis and neuroplasticity in Alzheimer's disease and Down syndrome Potter, Huntington
2011
7 4S p. e24-
1 p.
artikel
92 A key role for lysine residues in amyloid-β protein folding, assembly, and toxicity Lopes, Dahabada
2011
7 4S p. S465-S466
2 p.
artikel
93 Albumin capacity to bind Aβ: In vitro fluid phase assay Costa, Montse
2011
7 4S p. S133-
1 p.
artikel
94 Alcadein epsilon-cleavage followed by gamma-cleavage Piao, Yi
2011
7 4S p. S578-
1 p.
artikel
95 Alginate oligosaccharide protects against H2O2 -induced endoplasmic reticulum- and mitochondrial-mediated apoptotic cell death Khodagholi, Fariba
2011
7 4S p. S613-
1 p.
artikel
96 All-trans retinoic acid treatment of Alzheimer's disease transgenic mice Lerner, Alan
2011
7 4S p. S657-
1 p.
artikel
97 ALOIS - the next phase: a comprehensive study-based register of diagnostic studies (www.medicine.ox.ac.uk/alois) Noel-Storr, Anna
2011
7 4S p. S324-S325
2 p.
artikel
98 A long-term, open-label extension study evaluating the safety of extended-release memantine (28 mg) in patients with moderate to severe Alzheimer's disease Perhach, James
2011
7 4S p. e70-
1 p.
artikel
99 Alpha7 nicotinic receptor agonists interrupt the interaction between fibrillar amyloid and nicotinic receptor in Alzheimer's brain Ni, Ruiqing
2011
7 4S p. S468-
1 p.
artikel
100 Alteration in structural proteins in white matter injury is associated with vascular brain injury Sonnen, Joshua
2011
7 4S p. S305-
1 p.
artikel
101 Alteration of A beta-1-42 binding in red blood cells: a potential marker for Alzheimer's disease Liegeois, Corinne
2011
7 4S p. S155-
1 p.
artikel
102 Altered brain white matter integrity in carriers of the APOE epsilon4 allele with late onset depression: A risk for Alzheimer's disease? Lee, Chang Uk
2011
7 4S p. S234-
1 p.
artikel
103 Altered expression of the novel AD risk gene BIN1 interacts with the tau but not amyloid pathway in humans and flies Dermaut, Bart
2011
7 4S p. e2-
1 p.
artikel
104 Altered intrinsic functional connectivity of default mode network in a patient with posterior cortical dysfunction syndrome Balthazar, Marcio
2011
7 4S p. S54-
1 p.
artikel
105 Altered protein expression in pyramidal neurons in Alzheimer's disease Tjernberg, Lars
2011
7 4S p. S490-S491
2 p.
artikel
106 Altered running economy in the Tg2576 mouse model of Alzheimer's disease Calhoun, Brandon
2011
7 4S p. S516-S517
2 p.
artikel
107 Alternative gamma-secretase processing in sporadic Alzheimer's disease suggested by p3-Alc peptide, metabolic product of alcadein Hata, Saori
2011
7 4S p. S577-
1 p.
artikel
108 Alternative Splicing to and Extracellular TAU: The Initial Steps of TAU Pathology Progression in Tauopathies Liu, Fei
2011
7 4S p. S491-
1 p.
artikel
109 Alzeimer's Disease is An Energy Problem Not A Biomass Trouble Solis-Herrera, Arturo
2011
7 4S p. S802-
1 p.
artikel
110 Alzheimer disease cooperative study (ADCS) home based assessment: Designing trials with new technology Sano, Mary
2011
7 4S p. S513-
1 p.
artikel
111 Alzheimer Risk Variant Clusterin (CLU) and Brain Function During Aging Thambisetty, Madhav
2011
7 4S p. S196-
1 p.
artikel
112 Alzheimer risk variant complement component (3b/4b) receptor-1 (CR1) and brain function during aging Thambisetty, Madhav
2011
7 4S p. e31-
1 p.
artikel
113 Alzheimer's amyloidosis induces global changes in protein homeostasis in the brains of transgenic mice Xu, Guilian
2011
7 4S p. S562-
1 p.
artikel
114 Alzheimer's disease and Alcoholic Encephalopathy Liss, Leopold
2011
7 4S p. S604-
1 p.
artikel
115 Alzheimer's disease and cerebrovascular disease: Related or coexisting? Spies, Petra Elise
2011
7 4S p. S146-S147
2 p.
artikel
116 Alzheimer's disease and neurogenesis: Familial(r) signaling, new roles Lazarov, Orly
2011
7 4S p. S577-S578
2 p.
artikel
117 Alzheimer's disease and the ability to speak of self-as-agent in future contexts: description and analysis Asp, Elissa
2011
7 4S p. S155-
1 p.
artikel
118 Alzheimer's disease from a pathological point of view and what neurologists can learn from it Murray, Melissa
2011
7 4S p. S304-
1 p.
artikel
119 Alzheimer's disease genetics consortium: new Alzheimer's disease genes and gene interactions Beecham, Gary
2011
7 4S p. S85-
1 p.
artikel
120 Alzheimer’s Disease Hippocampus Micro-RNA Expression Bekris, Lynn
2011
7 4S p. S179-
1 p.
artikel
121 Alzheimer's disease in a young person Magda da Silva Bruscato, Ana
2011
7 4S p. S156-
1 p.
artikel
122 Alzheimer's disease instrument validation study in Asia Yu, Holly
2011
7 4S p. S763-
1 p.
artikel
123 Alzheimer's disease-like TAU forms and cell survival Rodriguez, Nelson Nunez
2011
7 4S p. S379-
1 p.
artikel
124 Alzheimer's disease patients' cognitive functions are enhanced following a new non-invasive non-pharmacological treatment Birbaumer, Niels
2011
7 4S p. S669-
1 p.
artikel
125 Alzheimer's disease reduces inter-hemispheric hippocampal functional connectivity Korolev, Igor
2011
7 4S p. S739-
1 p.
artikel
126 Alzheimer's disease subjects carrying the APOE4 allele have lower brain BACE1 levels than APOE3 carriers Decourt, Boris
2011
7 4S p. S134-S135
2 p.
artikel
127 Alzheimer’s Disease Susceptibility Loci: Evidence for Natural Selection and Altered Gene Expression Raj, Towfique
2011
7 4S p. S183-
1 p.
artikel
128 Alzheimer's in public health terms Splaine, Michael
2011
7 4S p. S619-
1 p.
artikel
129 Alzheimer's pathology, mixed pathologies and the clinical expression of dementia in the old and the oldest old James, Bryan
2011
7 4S p. S304-S305
2 p.
artikel
130 Alzheimer's-signature MRI biomarker predicts likelihood of Alzheimer's dementia in cognitively normal adults Dickerson, Brad
2011
7 4S p. S109-
1 p.
artikel
131 Alzheimer's signature MRI biomarker predicts likelihood of Alzheimer's dementia in cognitively normal adults Dickerson, Brad
2011
7 4S p. S24-S25
2 p.
artikel
132 Alzheimer's-specific data standards Cantillon, Marc
2011
7 4S p. S810-
1 p.
artikel
133 Ambulatory activity patterns in Alzheimer's disease based on living situation: Preliminary results Padala, Kalpana
2011
7 4S p. S630-
1 p.
artikel
134 aMCI delay recall performance is associated with white and grey matter abnormalities in the left hippocampal formation: A DTI and cortical thickness study Schoemaker, Dorothee
2011
7 4S p. S78-
1 p.
artikel
135 Ameliorative effect of Centella asiatica on memory dysfunction in D-galactose induced senescence mice Prakash, Atish
2011
7 4S p. e74-e75
nvt p.
artikel
136 Ameliorative effect of Centella asiatica on memory dysfunction in D-galactose–induced senescence mice Prakash, Atish Kumar
2011
7 4S p. S124-
1 p.
artikel
137 Aminopyrimidines as selective γ-secretase modulators for the potential treatment of AD Limberg, Anja
2011
7 4S p. S465-
1 p.
artikel
138 Amnestic MCI/ prodromal Alzheimer's disease with more severe memory deficit is indistinguishable from diagnosed Alzheimer disease: Implications for the validity of clinical trials and biomarkers Schneider, Lon
2011
7 4S p. S681-S682
2 p.
artikel
139 A modified method for 3D-SSP analyses of amyloid PET imaging Kaneta, Tomohiro
2011
7 4S p. S59-S60
2 p.
artikel
140 A Multiplex UPLC-MS/MS-based assay for amyloid β and related biomarker peptides in human cerebrospinal fluid Jenkins, Rand
2011
7 4S p. S320-
1 p.
artikel
141 Amygdala Atrophy Contributes to Smell Identification Deficit in Alzheimer’s Disease and Mild Cognitive Impairment Magerova, Hana
2011
7 4S p. S173-S174
2 p.
artikel
142 Amygdalar local structural differences in early- and late-onset Alzheimer's patients Cavedo, Enrica
2011
7 4S p. S337-
1 p.
artikel
143 Amygdalar local structural differences in early- and late-onset Alzheimer's patients Cavedo, Enrica
2011
7 4S p. S11-S12
2 p.
artikel
144 Amyloid and Microbleeds in different dementias: retained or drained? Teunissen, Charlotte
2011
7 4S p. S302-
1 p.
artikel
145 Amyloid beta (AB) nanoparticles employed to study intracellular tau protein interaction Hasan, Syed
2011
7 4S p. e22-
1 p.
artikel
146 Amyloid-beta43 is the potent pathological accelerator for Alzheimer's disease Saito, Takashi
2011
7 4S p. S397-
1 p.
artikel
147 Amyloid-beta-42 mimotope displaying M13 phages induce anti-amyloid beta 42 antibody without adjuvant Sugimura, Kazuhisa
2011
7 4S p. S473-S474
2 p.
artikel
148 Amyloid-Beta oligomers accumulate in the postsynaptic density fraction and reveal cognitive impairment in transgenic mice model of Alzheimer's disease Moustié, Olivier
2011
7 4S p. S505-
1 p.
artikel
149 Amyloid beta-peptide N-terminal processing Wang, Rong
2011
7 4S p. e25-
1 p.
artikel
150 Amyloid-beta peptide (1-42) oligomers induce p75NTR expression in hippocampus of mouse brain and SH-SY5Y human neuroblastoma cells Ito, Shingo
2011
7 4S p. S580-S581
2 p.
artikel
151 Amyloid-ß burden and neuropsychological test performance in cognitively normal first-degree relatives at varying genetic risk for Alzheimer's disease van Dyck, Christopher
2011
7 4S p. S236-
1 p.
artikel
152 Amyloid-ß burden and neuropsychological test performance in cognitively normal first-degree relatives at varying genetic risk for Alzheimer's disease van Dyck, Christopher
2011
7 4S p. S51-S52
2 p.
artikel
153 Amyloid deposition in non-demented elderly predicts longitudinal cognitive decline Rentz, Dorene
2011
7 4S p. S221-
1 p.
artikel
154 Amyloid deposition predicts regional and quantitative metabolic decline in patients with mild Alzheimer's disease Förster, Stefan
2011
7 4S p. S211-S212
2 p.
artikel
155 Amyloid imaging in atypical dementia using 11C-PIB PET Edison, Paul
2011
7 4S p. S108-S109
2 p.
artikel
156 Amyloid imaging in members of a family harbouring the Arctic APP mutation Schöll, Michael
2011
7 4S p. S303-
1 p.
artikel
157 Amyloid imaging in nondemented oldest-old Mathis, Chester
2011
7 4S p. S696-
1 p.
artikel
158 Amyloid imaging in nondemented oldest old Mathis, Chester
2011
7 4S p. S32-
1 p.
artikel
159 Amyloid imaging with [11C]SB-13 PET in patients with mild Alzheimer's disease: A test-retest reliability study of distribution volume ratio estimates Verhoeff, Nicolaas
2011
7 4S p. S727-S728
2 p.
artikel
160 Amyloid imaging with [11C]SB-13 PET in patients with mild Alzheimer's disease: A test-retest reliability study of distribution volume ratio estimates Verhoeff, Nicolaas
2011
7 4S p. S64-
1 p.
artikel
161 Amyloid-independent mechanisms of Alzheiemer's disease: The role of APP intracellular domain Pimplikar, Sanjay
2011
7 4S p. S415-
1 p.
artikel
162 Amyloid metabolism in Niemann-Pick type C disease Gustavsson, Mikael
2011
7 4S p. e22-
1 p.
artikel
163 Amyloid β oligomers as a potential biomarker for early—stage Alzheimer's disease Bruggink, Kim
2011
7 4S p. S131-
1 p.
artikel
164 Amyloid-β peptide binds to Cytochrome C Oxidase subunit 1 (COX1) Hernández, Luis
2011
7 4S p. S408-
1 p.
artikel
165 Amyloid precursor protein regulates SREBP-mediated neuronal lipid homeostasis in mice and humans Pierrot, Nathalie
2011
7 4S p. S572-
1 p.
artikel
166 An Abeta vaccine for canine cognitive dysfunction syndrome and Alzheimer's disease Bosch, Maria Neus
2011
7 4S p. S477-
1 p.
artikel
167 Analysis and characterization of soluble amyloid precursor protein (sAPP) across multiple CSF draws in Alzheimer's disease subjects and healthy controls Waring, Jeffrey
2011
7 4S p. S333-S334
2 p.
artikel
168 Analysis of autophagy and apoptosis gene regulation in neuronal cells infected Appelt, Denah
2011
7 4S p. S378-S379
2 p.
artikel
169 Analysis of iPS cell models of Alzheimer’s disease Abeliovich, Asa
2011
7 4S p. S119-
1 p.
artikel
170 Analysis of number of words and content of the discourse of patients with Alzheimer's disease in mild and moderate stages Lira, Juliana
2011
7 4S p. S253-
1 p.
artikel
171 Analysis of tau associated proteins in secreted exosomes: Clues to tau-mediated neurodegeneration? Saman, Sudad
2011
7 4S p. e2-e3
nvt p.
artikel
172 Analysis of the effectiveness of the intervention of multisensory stimulation (snoezelen room): experience of Alzheimer's disease special care unit Bonora, Annalisa
2011
7 4S p. S648-
1 p.
artikel
173 Analysis of the structural changes of the wild type peptide (AB22-35) using attentuated total reflectance infrared spectroscopy and ultraviolet visible spectroscopy Zawadski, Sarah
2011
7 4S p. S401-
1 p.
artikel
174 An approach to dealing with negative behaviors in patients with frontotemporal dementia Drubach, Daniel
2011
7 4S p. S628-
1 p.
artikel
175 An assessment of variability in CSF biomarkers in clinical experimental models: a meta-analysis Waring, Jeffrey
2011
7 4S p. S101-
1 p.
artikel
176 Anatomic correlates according to the phenotypes in progressive aphasia Kang, Hee Jin
2011
7 4S p. S340-
1 p.
artikel
177 An automated, operator-independent method for evaluating various brain areas of florbetaben PET scans to compare regional normal versus diseased beta-amyloid burdens Zubal, George
2011
7 4S p. S344-
1 p.
artikel
178 Androgen intervention therapy in a patient with familial Alzheimer's disease Martins, Ralph
2011
7 4S p. S610-
1 p.
artikel
179 An Effect of I143T PSEN1 Mutation on The Generation of Amyloid B in Culture Cells Sanjo, Nobuo
2011
7 4S p. S397-
1 p.
artikel
180 An Elderly's profile with Alzheimer's disease treated by the exceptional medicine program of São Carlos City (São Paulo, Brazil) Manzine, Patricia
2011
7 4S p. S639-
1 p.
artikel
181 Anesthesia and Alzheimer's disease neuropathogenic pathways Planel, Emmanuel
2011
7 4S p. S568-S569
2 p.
artikel
182 A Network of Protein Kinases and Sortilins Converges on Vps35 To Control A Generation Gandy, Sam
2011
7 4S p. S283-
1 p.
artikel
183 An evaluation of the potential role of a specialist outreach clinical pharmacist Maidment, Ian
2011
7 4S p. S799-
1 p.
artikel
184 An evidence-based caregiver intervention: Translation from research to practice Mittelman, Mary
2011
7 4S p. S492-S493
2 p.
artikel
185 A New Blood Biomarker for Alzheimer’s Disease: Proof of Concept in Human and in Transgenic Animal Models Sellal, Francois
2011
7 4S p. S288-
1 p.
artikel
186 A new evidence-based toolkit for optimising communication with people with dementia Young, Tony
2011
7 4S p. S646-S647
2 p.
artikel
187 A new function for the amyloid precursor protein partner PAT1 Dilsizoglu, Aysegul
2011
7 4S p. S379-
1 p.
artikel
188 A new immunoassay based on surface plasmon resonance for detection of β-amyloid oligomers Stravalaci, Matteo
2011
7 4S p. S398-
1 p.
artikel
189 A newly proposed method to define cerebellar reference region optimized for individual BF-227 PET: Clinical validation in a multi-center study Fujiwara, Ken
2011
7 4S p. e35-
1 p.
artikel
190 A new therapeutic strategy against Alzheimer's disease (AD) and other brain diseases: intracellular neurotransport delivery (i.nt.) of CB-NGF and CB-cargo conjugates may rescue AD and other brain diseases Wan, Xuancai
2011
7 4S p. e69-
1 p.
artikel
191 An exploratory analysis of the relationship between dependence and costs of care, both formal and informal, for people with dementia in Ireland Gillespie, Paddy
2011
7 4S p. S623-S624
2 p.
artikel
192 An fMRI study of music familiarity and brain activation in Alzheimer'S disease Jacova, Claudia
2011
7 4S p. S248-
1 p.
artikel
193 Angiotensin receptors blockers could be associated with a lower MMSE score decline in hypertensive patients with Alzheimer's disease Lu, Clara
2011
7 4S p. S798-
1 p.
artikel
194 Animal assisted therapy (AAT) on the evolution of cognitive disturbances Bono, Aldo
2011
7 4S p. e55-
1 p.
artikel
195 An index of vascular health is associated with white matter and hippocampal changes in individuals with mild cognitive impairment Jefferson, Angela
2011
7 4S p. S612-
1 p.
artikel
196 An Innovative outreach and service model of African-American recruitment for Alzheimer's research Farrar, Dorothy
2011
7 4S p. S593-
1 p.
artikel
197 An intervention tool for lower and middle-income countries: ‘Helping carers to care’ Wortmann, Marc
2011
7 4S p. S493-
1 p.
artikel
198 An investigation into insulin on pCREB after treated by ADDLs Run, Xiaoqin
2011
7 4S p. S396-
1 p.
artikel
199 An investigation into the prediction of vulnerability to carer burden in adult offspring carers of parents with dementia. Dodge, Suzanne
2011
7 4S p. S434-
1 p.
artikel
200 An MRI-derived definition of MCI-to-Alzheimer's conversion Aksu, Yaman
2011
7 4S p. e42-
1 p.
artikel
201 Annamaria Confaloni PhD Piscopo, Paola
2011
7 4S p. S201-
1 p.
artikel
202 A novel APP/Aβ mutation K16N produces highly toxic heteromeric Aβ oligomers Kaden, Daniela
2011
7 4S p. e3-
1 p.
artikel
203 A novel approach for monitoring tau aggregation in cell models of tauopathy by fluorescence-activated cell sorting (FACS) Pickhardt, Marcus
2011
7 4S p. S532-
1 p.
artikel
204 A novel approach to inhibit the deregulation of the kinases involved in neurodegenerative diseases Pant, Harish
2011
7 4S p. S775-S776
2 p.
artikel
205 A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(s)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole (mmbo) decreased tau phosphorylation and ameliorated cognitive deficits in a transgenic model of Alzheimer's disease Onishi, Tomohiro
2011
7 4S p. S482-
1 p.
artikel
206 A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia Galimberti, Daniela
2011
7 4S p. S202-
1 p.
artikel
207 A novel mechanism for axonal sorting of tau protein: A retrograde barrier at the axon initial segment Mandelkow, Eckhard
2011
7 4S p. S689-
1 p.
artikel
208 A novel mechanism for cognitive enhancement In aged dogs with the use of a calcium binding protein Milgram, Norton
2011
7 4S p. e10-e11
nvt p.
artikel
209 A novel medical food Souvenaid® for AD patients can be used safely in combination with an acetylcholinesterase inhibitor in an aged rat model de Wilde, Martijn
2011
7 4S p. S795-
1 p.
artikel
210 A novel microRNA interaction relevant to alzheimer's disease pathogenesis and drug target discovery: miR-346 induces expression of amyloid precursor protein Long, Justin
2011
7 4S p. S566-S567
2 p.
artikel
211 A novel MRI-compatible brain ventricle phantom for validation of lateral ventricle segmentation programs Khan, Amanda
2011
7 4S p. S44-
1 p.
artikel
212 A novel MRI-compatible brain ventricle phantom for validation of lateral ventricle segmentation programs Khan, Amanda
2011
7 4S p. S375-S376
2 p.
artikel
213 A novel perspective for Alzheimer's disease: Vitamin D receptor suppression by amyloid-beta and preventing the amyloid-beta induced alterations of LVSCC-A1C, calbindin-D28k and iNOS expression and NGF release by vitamin D Dursun, Erdinc
2011
7 4S p. S122-
1 p.
artikel
214 A novel screening approach for MCI/AD Luis, Cheryl
2011
7 4S p. S254-S255
2 p.
artikel
215 A novel serum biomarker measuring degradation of tau allows the detection of Alzheimer's disease in serum samples Henriksen, Kim
2011
7 4S p. e3-e4
nvt p.
artikel
216 Antemortem hippocampal atrophy on MRI predicts presence of Alzheimer's disease pathology in pathologically confirmed Lewy body disease Kantarci, Kejal
2011
7 4S p. S14-
1 p.
artikel
217 Antemortem hippocampal atrophy predicts presence of Alzheimer's disease pathology in pathologically proven lewy body disease Kantarci, Kejal
2011
7 4S p. S302-S303
2 p.
artikel
218 Antemortem increase in gray matter diffusivity is associated with decreased neuronal density Murray, Melissa
2011
7 4S p. S61-
1 p.
artikel
219 Antemortem increase in gray matter diffusivity is associated with decreased neuronal density Murray, Melissa
2011
7 4S p. S341-S342
2 p.
artikel
220 Anti-Aβ immunotherapy results in a dramatic shift in the inflammatory profile: Implications for amyloid reductions and vascular complications Wilcock, Donna
2011
7 4S p. S812-
1 p.
artikel
221 Antibodies against APP β -Secretase Cleavage Site affect Aβ and tau aggregation and toxicity Rabinovich, Inna
2011
7 4S p. S470-S471
2 p.
artikel
222 Antidepressants are associated with lower brain amyloid in cognitively normal humans Sheline, Yvette
2011
7 4S p. S109-S110
2 p.
artikel
223 Antidepressants are Associated with Lower Brain Amyloid in Cognitively Normal Humans Sheline, Yvette
2011
7 4S p. S45-
1 p.
artikel
224 Antisense to GSK-3 beta improves learning and memory in aged SAMP8 mice Morley, John
2011
7 4S p. S573-
1 p.
artikel
225 Anxiety is related to Alzheimer's disease markers in cerebrospinal fluid of subjects with mild cognitive impairment Ramakers, Inez
2011
7 4S p. S144-
1 p.
artikel
226 Apathy in Alzheimer's disease Seidl, Ulrich
2011
7 4S p. S640-
1 p.
artikel
227 Apathy in Alzheimer's disease: Towards an integrated research agenda Lanctôt, Krista
2011
7 4S p. S92-
1 p.
artikel
228 Apathy-like syndrome associated with early lesion in the triple-transgenic 3xTgAD mouse Lauritzen, Inger
2011
7 4S p. S567-
1 p.
artikel
229 Apathy without depression is associated with cardiovascular risk factors and history of stroke Richard, Edo
2011
7 4S p. S605-
1 p.
artikel
230 A Phase 1, dose escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple oral daily doses of ELND006 in healthy elderly subjects Liang, Earvin
2011
7 4S p. S465-
1 p.
artikel
231 A phase I, double-blind, placebo-controlled, randomized, multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of PF 04447943 in mild-to-moderate Alzheimer's disease subjects on stable donepezil therapy Evans, Rebecca
2011
7 4S p. S781-
1 p.
artikel
232 A pilot phase IV open label study investigating the safety and tolerability of switching from the Exelon patch 9.5mg daily to Aricept 23mg daily in patients with moderate to severe AD Sabbagh, Marwan
2011
7 4S p. e63-
1 p.
artikel
233 APOE ϵ4 affects visual memory binding in amnestic mild cognitive impairment Laczó, Jan
2011
7 4S p. S540-S541
2 p.
artikel
234 APOE-ϵ4 allele and neuropsychiatric symptoms in MCI: findings from the DESCRIPA study Elias-Sonnenschein, Lyzel
2011
7 4S p. S351-
1 p.
artikel
235 ApoE and ABCG2 expression Zhang, W.
2011
7 4S p. S711-
1 p.
artikel
236 APOE E4 effects on florbetapir F18 PET in Alzheimer's disease, mild cognitive impairment and normal aging Fleisher, Adam
2011
7 4S p. S48-S49
2 p.
artikel
237 APOE ϵ4 effects on florbetapir F18 PET in Alzheimer's disease, mild cognitive impairment and normal aging Fleisher, Adam
2011
7 4S p. S232-
1 p.
artikel
238 APOE e4 status modulates the association of plasma and cortical Aβ: Relation of plasma Aβ and [11C]PiB PET in the ADNI cohort Saykin, Andrew
2011
7 4S p. e39-
1 p.
artikel
239 APOE genotype and longitudinal changes in cerebral blood flow on MRI: The SMART-MR study. Muller, Majon
2011
7 4S p. S357-
1 p.
artikel
240 APOE genotype differences in plasma protein levels in young and elderly cohorts Teng, Edmond
2011
7 4S p. S148-
1 p.
artikel
241 APOE Genotype is Associated with Cerebrospinal Fluid and Plasma APOE Levels But Not with APOE Expression Levels Cruchaga, Carlos
2011
7 4S p. S182-S183
2 p.
artikel
242 APOE is associated with Vascular Dementia - using alzgene-like approaches to investigate susceptibility genes for vascular cognitive impairment Kehoe, Patrick
2011
7 4S p. S756-
1 p.
artikel
243 APOE4 plays a role in Abeta-mediated synapse loss in Alzheimer's disease Holtzman, David
2011
7 4S p. S103-S104
2 p.
artikel
244 Apolipoprotein E isoform related clearance of amyloid-β by primary cortical astrocytes Sanchez, Sandrine
2011
7 4S p. S526-
1 p.
artikel
245 Apomorphine treatment in Alzheimer's mice promoting amyloid-beta degradation Ohyagi, Yasumasa
2011
7 4S p. S298-
1 p.
artikel
246 APP accelerates death and alters physical connectivity of mouse olfactory sensory neurons Albers, Mark
2011
7 4S p. S98-
1 p.
artikel
247 APP intracellular domain enhances neurite outgrowth through gαs coupling to adenylate cyclase signaling Deyts, Carole
2011
7 4S p. S582-
1 p.
artikel
248 Application of a physiologically relevant mathematical model supporting the quantitative importance of the clearance of brain Aβ peptide to CSF in the healthy normal rat Hickman, Dean
2011
7 4S p. S98-
1 p.
artikel
249 Application of molecular topology in Alzheimer's disease drug discovery Pasinetti, Giulio
2011
7 4S p. e62-
1 p.
artikel
250 Application of the Predictad Software Tool to the Differentiation Between Stable and Progressive MCI Waldemar, Gunhild
2011
7 4S p. S169-
1 p.
artikel
251 Application/qualification of disease models for improved treatment development in Alzheimer's Disease Corrigan, Brian
2011
7 4S p. S810-S811
2 p.
artikel
252 APP metabolism in brain of Alcadein alpha CTF transgenic mice Kimura, Ayano
2011
7 4S p. S577-
1 p.
artikel
253 APP/PS1 transgenic mice overexpressing SREBP2 as a new model to study the pathogenic role of cholesterol in Alzheimer's disease (AD) Barbero, Elisabet
2011
7 4S p. S517-
1 p.
artikel
254 Approaches to NMR of mixed Aβ oligomers Williams, Joshua
2011
7 4S p. S391-
1 p.
artikel
255 APP, tau and presenilin: The metal ion regulatory proteins of Alzheimer's disease Bush, Ashley
2011
7 4S p. S805-
1 p.
artikel
256 APP/tau interaction and axonal transport Goldstein, Lawrence
2011
7 4S p. S676-
1 p.
artikel
257 Apraxia of speech and orofacial apraxia in Alzheimer's disease Cera, Maysa
2011
7 4S p. S240-
1 p.
artikel
258 A prediction rule of CSF biomarkers for Alzheimer's disease in clinical practice Spies, Petra
2011
7 4S p. S106-S107
2 p.
artikel
259 A quantitative cellular sensor of protein aggregation Esteras-Chopo, Alexandra
2011
7 4S p. S460-
1 p.
artikel
260 A randomized, double-blind, placebo-controlled dose-finding trial of intravenous immunoglobulin (IVIG; Octagam® 10%, Octapharma AG) in patients with mild to moderate Alzheimer's disease (GAM10-04) Dodel, Richard
2011
7 4S p. e55-e56
nvt p.
artikel
261 A randomized, double-blind, placebo-controlled 16 week study of the H3 receptor antagonist GSK239512 in subjects with mild-to-moderate Alzheimer's disease (AD) Grove, Richard
2011
7 4S p. e58-e59
nvt p.
artikel
262 A randomized trial examining recall and distress after telephone versus in-person disclosure of genetic risk information about Alzheimer's disease: the REVEAL study Green, Robert
2011
7 4S p. S643-S644
2 p.
artikel
263 Are CSF biomarkers useful for the diagnosis of probable Dementia with lewy bodies? Bombois, Stephanie
2011
7 4S p. S131-
1 p.
artikel
264 Are platelet BACE1 levels altered in Alzheimer's disease patients? Decourt, Boris
2011
7 4S p. S317-
1 p.
artikel
265 Are SNPs associated with Alzheimer's disease also associated with cognition and structural brain changes in a relatively young population? Verhaaren, Benjamin
2011
7 4S p. S237-
1 p.
artikel
266 Are SNPs associated with Alzheimer's disease also associated with cognition and structural brain changes in a relatively young population? Verhaaren, Benjamin
2011
7 4S p. S52-S53
2 p.
artikel
267 A Role for hunger-promoting neurons in the etiology of neurodegeneration Horvath, Tamas
2011
7 4S p. S807-
1 p.
artikel
268 A role for hypertension in CAA, neuroinflammation and neuropathology In Alzheimer's? Cribbs, David
2011
7 4S p. S811-S812
2 p.
artikel
269 A role for TDP-43 in tau gene expression regulation Simone, Roberto
2011
7 4S p. S558-S560
3 p.
artikel
270 Arterial calcifications as a marker of vascular brain disease Bos, Daniel
2011
7 4S p. S731-S732
2 p.
artikel
271 Arterial calcifications as a marker of vascular brain disease Bos, Daniel
2011
7 4S p. S71-
1 p.
artikel
272 Arterial calcifications in relation to cognitive function and structural brain changes Bos, Daniel
2011
7 4S p. S295-
1 p.
artikel
273 Arterial calcifications in relation to cognitive function and structural brain changes Bos, Daniel
2011
7 4S p. S71-S72
2 p.
artikel
274 Arterial stiffness is associated with cerebral small vessel disease Ikram, Mohammad
2011
7 4S p. S295-
1 p.
artikel
275 Arterial stiffness is associated with cerebral small vessel disease Ikram, Mohammad
2011
7 4S p. S68-
1 p.
artikel
276 A selective ORL1 antagonist enhances hippocampal function and reverses pharmacologically induced cognitive deficits in rodents Roof, Robin
2011
7 4S p. S772-S773
2 p.
artikel
277 A Serum protein-based algorithm for the detection of Alzheimer's disease O'Bryant, Sidney
2011
7 4S p. S674-S675
2 p.
artikel
278 Asparagine Endopeptidase (AEP) is activated in Alzheimer's disease brain and induces I2PP2A cleavage Basurto-Islas, Gustavo
2011
7 4S p. S407-
1 p.
artikel
279 Aβ-specific antibodies induced by active immunotherapy CAD106 engage Aβ in plasma in AD patients Winblad, Bengt
2011
7 4S p. S334-
1 p.
artikel
280 A specific relationship between hippocampal CA1 subfield atrophy and episodic memory encoding in amnestic mild cognitive impairment Fouquet, Marine
2011
7 4S p. S734-S735
2 p.
artikel
281 A specific relationship between hippocampal CA1 subfield atrophy and episodic memory encoding in amnestic mild cognitive impairment Fouquet, Marine
2011
7 4S p. S73-S74
2 p.
artikel
282 Assessing depressive symptoms in communication-impaired older persons in long-term care facilities: The Feeling Tone Questionnaire (FTQ) and its psychometric properties Toner, John
2011
7 4S p. S454-
1 p.
artikel
283 Assessing family caregiver skill Farran, Carol
2011
7 4S p. S450-S451
2 p.
artikel
284 Assessing the ability to use everyday technology in people with MCI or Alzheimer's disease Nygard, Louise
2011
7 4S p. S678-
1 p.
artikel
285 Assessing the impact of APOE genotype on regional brain volume McGeown, William
2011
7 4S p. S235-
1 p.
artikel
286 Assessing treatment responsiveness of anti-dementia drugs with the SymptomGuide™ Rockwood, Kenneth
2011
7 4S p. S164-S165
2 p.
artikel
287 Assessment of BIN1 involvement in the Alzheimer's Disease pathophysiological process Hansmannel, Franck
2011
7 4S p. S386-S387
2 p.
artikel
288 Assessment of caregiver's specific social competencies in dementia care: Development and validation of a self-report instrument Krause, Katharina
2011
7 4S p. S453-
1 p.
artikel
289 Assessment of PF-04995274 in scopolamine-disrupted Morris water maze compared to and in combination with donepezil Roof, Robin
2011
7 4S p. S772-
1 p.
artikel
290 Assessment of physical activity and body composition of free-living elderly men with and without Alzheimer’s disease Wlodarek, Dariusz
2011
7 4S p. S627-
1 p.
artikel
291 Assess the importance of the objective memory deficit in the association of APOE4 with mild cognitive impairment and its relation with a fast-progression to Alzheimer's disease Marcos, Alberto
2011
7 4S p. S200-
1 p.
artikel
292 Assistive technologies for older adults with Alzheimer's disease: the Lusage user-lab experience Pino, Maribel
2011
7 4S p. S442-
1 p.
artikel
293 Association and expression analyses with SNPs in TOMM40 in Alzheimer's disease Goate, Alison
2011
7 4S p. S93-S94
2 p.
artikel
294 Association Between Apolipoprotein ε4 and Survival Following Onset of Alzheimer’s Disease in Korean Elderly Kim, Shin Gyeom
2011
7 4S p. S187-S188
2 p.
artikel
295 Association between cognitive deterioration and lifestyle-related diseases - study on normal populations attending comprehensive medical checkups Suzuki, Kazushi
2011
7 4S p. S546-
1 p.
artikel
296 Association between IgM antibodies to herpes simplex virus and plasma amyloid-beta levels Feart, Catherine
2011
7 4S p. S564-
1 p.
artikel
297 Association between neuropathological features of Alzheimer's disease and dementia in the very old versus the young old Farfel, Jose
2011
7 4S p. S700-S701
2 p.
artikel
298 Association between neuropathology and spatial learning in transgenic hAPPSL × hTAU crossbred mice Flunkert, Stefanie
2011
7 4S p. S519-
1 p.
artikel
299 Association of brain atrophy and vascular white matter lesions with CERAD score in Alzheimer's disease Bilello, Michel
2011
7 4S p. S205-
1 p.
artikel
300 Association of brain atrophy and vascular white matter lesions with CERAD score in Alzheimer's disease Bilello, Michel
2011
7 4S p. S21-
1 p.
artikel
301 Association of C-reactive protein with mild cognitive impairment and its subtypes in the German Heinz Nixdorf Recall Study cohort Dlugaj, Martha
2011
7 4S p. S350-S351
2 p.
artikel
302 Association of disease severity with VBM measured reduced regional gray matter volumes in Alzheimer's disease patients Huang, Qiu
2011
7 4S p. S228-
1 p.
artikel
303 Association of HDL cholesterol level with the severity of Alzheimer's disease and improvement following exercise Vreugdenhil, Anthea
2011
7 4S p. S95-
1 p.
artikel
304 Association of Interleukin-1β Haplotypes and Alzheimer’s Disease Payão, Spencer
2011
7 4S p. S191-
1 p.
artikel
305 Association of intermediate-length polyQ expansions in ATXN2 with ALS but not FTLD in a flanders-belgian cohort Van Langenhove, Tim
2011
7 4S p. S688-
1 p.
artikel
306 Association of plasma β-amyloid and bdnf levels: A pilot study in treatment-resistant depressed patients Moroni, Ilenia
2011
7 4S p. S142-
1 p.
artikel
307 Association of plasma amyloid beta peptide and anti-amyloid antibodies with risk of dementia in individuals with down syndrome Coppus, Antonia
2011
7 4S p. S384-
1 p.
artikel
308 Association of plasma Amyloid Beta peptides with blood pressure in the elderly Lambert, Jean-Charles
2011
7 4S p. S355-
1 p.
artikel
309 Association of PON2 Ser311Cys Polymorphism with Brain White Matter Lesions Assareh, Arezoo
2011
7 4S p. S177-S178
2 p.
artikel
310 Association of pre-baseline fish oil supplement use with rates of brain atrophy and cognitive decline in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Cohort Daiello, Lori
2011
7 4S p. S592-S593
2 p.
artikel
311 Association of pre-baseline fish oil supplement use with rates of brain atrophy and cognitive decline in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort Daiello, Lori
2011
7 4S p. S609-
1 p.
artikel
312 Association of the APOE -219 Polymorphism with Alzheimer’s Disease: The Prospective Three City Study Richard, Florence
2011
7 4S p. S193-
1 p.
artikel
313 Associations Between APOE ε4 and Instrumental Daily Activities of Living in A Community Sample of Older Adults Mather, Karen
2011
7 4S p. S190-
1 p.
artikel
314 Association study of recently reported AD risk variants with cerebrospinal fluid AD biomarker levels Bailey, Matthew
2011
7 4S p. S313-
1 p.
artikel
315 A stable G-quadruplex within the ADAM10 5'-UTR is involved in translational repression of ADAM10 Lammich, Sven
2011
7 4S p. S408-S409
2 p.
artikel
316 Astrocytes but not neurons are responsible for the hippocampal increase of amyloid beta peptide induced by neurotoxin quinolinic acid Okuno, Alato
2011
7 4S p. S399-
1 p.
artikel
317 A study of correlation between the mini mental state examination score, grey matter atrophy and potentially Alzheimer's disease-related plasma biomarkers Waragai, Masaaki
2011
7 4S p. S150-
1 p.
artikel
318 A study on the clinical profile and socio-cultural factors influencing diagnosis of mild cognitive impairment and dementia from a memory clinic in urban South India Ellajosyula, Ratnavalli
2011
7 4S p. S157-S158
2 p.
artikel
319 A synthetic amino acid substitution of Tyr10 in Abeta peptide sequence acts as a dominant negative in amyloidogenesis Mazarguil, Honoree
2011
7 4S p. S576-
1 p.
artikel
320 A technology-based psycho-educational intervention for minority Alzheimer's Disease caregivers Czaja, Sara
2011
7 4S p. S430-S431
2 p.
artikel
321 A technology-based socialization intervention for cognitive health Jimison, Holly
2011
7 4S p. S612-
1 p.
artikel
322 Atherosclerosis, aging, dementia and Alzheimer's disease O'Brien, Richard
2011
7 4S p. S485-
1 p.
artikel
323 Atherosclerosis and progression of brain atrophy: The SMART-MR study Muller, Majon
2011
7 4S p. S296-
1 p.
artikel
324 Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice Abe, Koji
2011
7 4S p. S532-
1 p.
artikel
325 ATR-IR and UV-VIS studies of the Iowa mutation show an increased rate of beta sheet formation Reinsalu, Sean
2011
7 4S p. S396-
1 p.
artikel
326 Atrophic cortical networks in Alzheimer disease: More than just the default network McGinnis, Scott
2011
7 4S p. S739-S740
2 p.
artikel
327 Atrophy specific MRI brain template for Alzheimer's disease and mild cognitive impairment Fonov, Vladimir
2011
7 4S p. S717-
1 p.
artikel
328 Atrophy-specific MRI brain template for Alzheimer's disease and mild cognitive impairment Fonov, Vladimir
2011
7 4S p. S58-
1 p.
artikel
329 Attachment representations and well-being in people with dementia and their caregivers Nelis, Sharon
2011
7 4S p. S625-
1 p.
artikel
330 Attenuated anti-aggregation effects of magnetite nanoparticles in cerebrospinal fluid of people with Alzheimer's disease Ripova, Daniela
2011
7 4S p. e71-
1 p.
artikel
331 Attenuated total reflectance: infrared spectroscopic analysis of the Alzheimer's peptide, dutch mutant with E22Q point mutation Kravetz, Ryan
2011
7 4S p. S388-
1 p.
artikel
332 Audiovisual integration of normal aged controls compared to patients with mild cognitive impairment and Alzheimer's disease Wu, Jinglong
2011
7 4S p. S270-
1 p.
artikel
333 Author Index 2011
7 4S p. S814-S862
49 p.
artikel
334 Auto-correcting shape-based segmentation of the hippocampus on 1.5T MR images van Stralen, Marijn
2011
7 4S p. S726-S727
2 p.
artikel
335 Auto-correcting shape-based segmentation of the hippocampus on 1.5T MR images van Stralen, Marijn
2011
7 4S p. S64-
1 p.
artikel
336 Automated detection of beta-amyloid–related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI Teipel, Stefan
2011
7 4S p. S10-
1 p.
artikel
337 Automated diagnostic classifiers for cognitively normal and mild cognitive impairment subjects using imaging, genotyping, and gene expression Apostolova, Liana G.
2011
7 4S p. S128-S129
2 p.
artikel
338 Automated Diagnostic Classifiers Using Imaging, Genotyping, and Gene Expression Data Apostolova, Liana
2011
7 4S p. S46-S47
2 p.
artikel
339 Automated quantification of [18F]flutemetamol amyloid imaging data Thurfjell, Lennart
2011
7 4S p. S726-
1 p.
artikel
340 Automated quantification of hippocampal asymmetry in MRI in semantic dementia and Alzheimer's disease Leung, Kelvin
2011
7 4S p. S16-
1 p.
artikel
341 Automated regional and voxel-wise quantification of florbetaben beta-amyloid brain PET Barthel, Henryk
2011
7 4S p. S54-S55
2 p.
artikel
342 Automated segmentation of the thalamus for measurement of MR diffusion indices: evaluation and application to familial Alzheimer's disease Keihaninejad, Shiva
2011
7 4S p. S50-
1 p.
artikel
343 Automated WML classification Selnes, Per
2011
7 4S p. S63-
1 p.
artikel
344 Automatic analysis of hands clapping in severe Alzheimer patient via computer vision techniques Ozturk, Ovgu
2011
7 4S p. S454-
1 p.
artikel
345 Automatic segmentation of hippocampus in Alzheimer's disease Thurfjell, Lennart
2011
7 4S p. S226-
1 p.
artikel
346 Automatic video monitoring system to detect apathy in Alzheimer's disease Mulin, Emmanuel
2011
7 4S p. S455-
1 p.
artikel
347 Autonomy at home and early diagnosis in AD: Utility of video indexing applied to clinical issues, the IMMED project Gaestel, Yann
2011
7 4S p. S245-
1 p.
artikel
348 Autophagic-lysosomal dysfunction in glucocerebrosidase-associated dementia with lewy bodies Yu, W. Haung
2011
7 4S p. S686-
1 p.
artikel
349 A visual rating system for combined deep and periventricular white matter hyperintensities: CREDOS (Clinical Research Center for Dementia of South Korea) study Noh, Young
2011
7 4S p. e38-
1 p.
artikel
350 Awareness and neuropsychiatric symptoms: are they common features in mild cognitive impairment patients? Pagni, Cristina
2011
7 4S p. S259-S260
2 p.
artikel
351 A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease Nakamura, Yu
2011
7 4S p. S786-
1 p.
artikel
352 Axonal neuritic pathology induces early presynaptic alterations in ps1/APP Alzheimer's mice hippocampus Sanchez-Varo, Raquel
2011
7 4S p. S527-
1 p.
artikel
353 Axonal transport of the ubiquitin-proteasome system and it relevance for protein degradation Otero, Maria Gabriela
2011
7 4S p. S562-S564
3 p.
artikel
354 A 5-year longitudinal subcortical ischemic mild cognitive impairment study (SIMS): Study design and baseline clinical characteristics Kim, Chi Hun
2011
7 4S p. e47-
1 p.
artikel
355 BACE1 activity is modulated by cell-associated sphingosine-1-phosphate Tomita, Taisuke
2011
7 4S p. S411-
1 p.
artikel
356 Balance, gait, postural stability, and falls in mild cognitive impairment: The Canton ticino study Quadri, Pierluigi
2011
7 4S p. S544-
1 p.
artikel
357 Baseline cerebrospinal fluid markers in healthy middle-aged adults predict brain health at three-year follow-up Bendlin, Barbara
2011
7 4S p. e4-
1 p.
artikel
358 Baseline cognition and education level as predictors for response to acetylcholinesterase inhibitor in Alzheimer's disease Weng, Pei-Hsuan
2011
7 4S p. S802-S803
2 p.
artikel
359 Baseline memory performance as a predictor of neurocognitive outcome of first-episode late-onset depression Zhang, Na
2011
7 4S p. S619-
1 p.
artikel
360 Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: A population-based study Roberts, Rosebud
2011
7 4S p. S692-
1 p.
artikel
361 Behavioral abnormalities are associated with milder dementia in Alzheimer's disease than in dementia with lewy bodies Salmon, David P.
2011
7 4S p. S165-S166
2 p.
artikel
362 Behavioral and neuropathological characterization of a viral-based model of amyloid pathology Cacquevel, Matthias
2011
7 4S p. S122-
1 p.
artikel
363 Behavioral symptoms in mild cognitive impairment as compared to Alzheimer's disease and healthy elderly Van der Mussele, Stefan
2011
7 4S p. S547-
1 p.
artikel
364 Behavioral variant of Alzheimer's disease in an old woman mimicking frontotemporal dementia: Diagnosis contribution of CSF biomarkers Lapalus, Pauline
2011
7 4S p. S143-S144
2 p.
artikel
365 Beliefs about cognitive loss among older African-and Caribbean-American adults McKenzie, Sharon
2011
7 4S p. S624-S625
2 p.
artikel
366 Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function in elderly people with very mild dementia in Japan Hashimoto, Michio
2011
7 4S p. S610-S611
2 p.
artikel
367 Best prevention: Active screening versus patient education Spiru, Luiza
2011
7 4S p. S606-
1 p.
artikel
368 Beta-amyloid binding of [3]AZD4694 and [3H]AV45 in vitro Jeppsson, Fredrik
2011
7 4S p. S42-S43
2 p.
artikel
369 Bilingualism and incident dementia risk: Results from the Einstein Aging Study Sanders, Amy
2011
7 4S p. S363-S364
2 p.
artikel
370 BIN1 and Picalm Are Associated With Alzheimer's Disease and CSF Tau Levels In The Flanders-Belgian Population Van Cauwenberghe, Caroline
2011
7 4S p. S497-
1 p.
artikel
371 Bioanalytical techniques to analyze a single point mutation of the E22Q Dutch Alzheimer's disease peptide Hynes, Forest
2011
7 4S p. S387-
1 p.
artikel
372 Bio-barcode assay: Development of a sensitive technique to detect Alzheimer's disease at an early stage Müller, Mareike
2011
7 4S p. S141-S142
2 p.
artikel
373 Biochemical analysis of wild-type Bri peptides in plasma obtained from non-FBD subjects Tomidokoro, Yasushi
2011
7 4S p. S764-
1 p.
artikel
374 Biochemical Biomarkers of Depressive Symptoms in ADNI Arnold, Steven
2011
7 4S p. S312-
1 p.
artikel
375 Biochemical characterization of the TG2576 mouse model: Age-dependent levels of Amyloid-beta species and other APP processing fragments in plasma and brain Appelkvist, Paulina
2011
7 4S p. S518-S519
2 p.
artikel
376 Biological consequences of BACE1-dependent processing of neuregulin Willem, Michael
2011
7 4S p. S412-
1 p.
artikel
377 Biomarker Qualification in Alzheimer's Disease Soares, Holly
2011
7 4S p. S330-
1 p.
artikel
378 Biomarkers across other neurodegenerative diseases as Parkinson's disease (PD) Kirby, Louis
2011
7 4S p. S811-
1 p.
artikel
379 Biomarkers associated with cardiovascular risk in the texas Alzheimer's Disease Research and Care Consortium (TARCC) Cohort: LpPla2 and Homocysteine Doody, Rachelle
2011
7 4S p. S317-S318
2 p.
artikel
380 Biomarkers in neurodegenerative diseases: The Dutch Parelsnoer Initiative Aalten, Pauline
2011
7 4S p. S346-
1 p.
artikel
381 Blood-brain barrier p-glycoprotein function in Alzheimer's disease van Assema, Danielle M.E.
2011
7 4S p. S110-
1 p.
artikel
382 Blood, Plasma and Serum Biomarkers of Preclinical Alzheimer's Disease Hampel, Harald
2011
7 4S p. S281-
1 p.
artikel
383 Blood pressure and depression affect performance on cognitive tests in a biracial (black-white) middle-age population: The Bogalusa heart study Gustat, Jeanette
2011
7 4S p. S601-
1 p.
artikel
384 Blood transcriptomic signatures of Alzheimer's patients treated with a novel Alzheimer's disease drug, EHT 0202, allow identification of novel potential biomarkers correlated with treatment response and efficacy Desire, Laurent
2011
7 4S p. e13-
1 p.
artikel
385 BMI, MMSE, ADL, APOE and MORTALITY: The TREVISO LONGEVA (TRELONG) Study Gustafson, Deborah
2011
7 4S p. S594-S595
2 p.
artikel
386 BMP4/NOGGIN contribute to abnormal neurogenesis in the adult hippocampal of APPSWE/PS1 e9 transgenic mouse model of Alzheimer's disease Tang, Jun
2011
7 4S p. S506-
1 p.
artikel
387 Body adiposity in later life and the incidence of dementia: The Health in Men study Brian, Power
2011
7 4S p. S351-S352
2 p.
artikel
388 Body Dysmorphic Disorder Dripts Onward Frontotemporal Dementia Fiori, Patrizia
2011
7 4S p. S275-
1 p.
artikel
389 Bradykinin B1 receptor blockade in the treatment of Alzheimer's disease: improvement of cognitive and cerebrovascular functions and reduction of amyloidosis Lacoste, Baptiste
2011
7 4S p. S512-S513
2 p.
artikel
390 Brain Barrier: Alzheimer's disease and therapeutic options Begley, David
2011
7 4S p. S808-
1 p.
artikel
391 Brain [11C]-PIB uptake reflects beta-amyloid burden detected by immunohistochemistry in frontal cortex biopsy specimens Rinne, Juha
2011
7 4S p. S230-S231
2 p.
artikel
392 Brain endothelial cells produce amyloid-β from amyloid precursor protein 770 and preferentially secrete the O-glycosylated form Tachida, Yuriko
2011
7 4S p. S590-
1 p.
artikel
393 Brain glucose metabolism in patients with mild to moderate Alzheimer's disease before and after six months treatment with intravenous immunoglobulin (octagam 10%): A phase II double blind, placebo-controlled multi-center study Rominger, Axel
2011
7 4S p. e39-
1 p.
artikel
394 Brain insulin resistance demonstrated in Alzheimer's disease is closely associated with elevated IRS-1 pS and cognitive deficits Talbot, Konrad
2011
7 4S p. S683-
1 p.
artikel
395 Brain metabolism study in frail elderly Peiffer, Sophie
2011
7 4S p. S218-
1 p.
artikel
396 Brain MRI predictors of global and domain specific cognitive function at 10 years follow up: ARIC brain MRI study Coker, Laura
2011
7 4S p. S733-
1 p.
artikel
397 Brain oxidative stress and peripheral infection in lipopolysaccharide-treated rats: The possible contribution in Alzheimer's disease Massicot, France
2011
7 4S p. S127-S128
2 p.
artikel
398 Brain regions underlying distinct groups of “delusional ideas” (BEHAVE-AD-FW) in Alzheimer's Dementia: The osaki-tajiri project Nakatsuka, Masahiro
2011
7 4S p. S741-S742
2 p.
artikel
399 Brains for dementia research providing human tissue for dementia research to further understanding and aid treatment discovery Hayes, Gillian
2011
7 4S p. S702-
1 p.
artikel
400 Brain volume changes in recently menopausal women in a hormone treatment trial Kantarci, Kejal
2011
7 4S p. S611-
1 p.
artikel
401 BRICHOS - A novel anti-amyloid chaperone domain Johansson, Jan
2011
7 4S p. S402-
1 p.
artikel
402 Brief screening for mild cognitive impairment: initial validation of the Montreal cognitive assessment (MoCA) in Brazilian elderly Memória, Cláudia
2011
7 4S p. S256-
1 p.
artikel
403 Butyrylcholinesterase, Aβ and thioflavin-S plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer's disease Darvesh, Sultan
2011
7 4S p. S518-
1 p.
artikel
404 Butyrylcholinesterase inhibitors modulate cytokines production in peripheral blood mononuclear cells Kamal, Mohammad
2011
7 4S p. S671-S672
2 p.
artikel
405 CADASIL-Like MRI Hyperintensities in a Case of Neuropathologically Confirmed Alzheimer’s Disease Paquet, Claire
2011
7 4S p. S174-S175
2 p.
artikel
406 Callosal atrophy in mild cognitive impairment and Alzheimer's disease Chao, Linda
2011
7 4S p. S207-
1 p.
artikel
407 Caloric intake, but not the Mediterranean diet, is associated with cognition and mild cognitive impairment Cherbuin, Nicolas
2011
7 4S p. S691-
1 p.
artikel
408 Cam-CAN study protocol: Cambridge Centre for Ageing and Neuroscience Minett, Thais
2011
7 4S p. S371-
1 p.
artikel
409 Candidate-based search for Amyloid Precursor Protein ligands that modulate α-secretase cleavage Rice, Heather
2011
7 4S p. S409-S410
2 p.
artikel
410 Can Hippocampal Size Predict Cognitive Impairment in Post-Stroke Patients? Korczyn, Amos
2011
7 4S p. S214-
1 p.
artikel
411 Can informant reports be trusted? Informant perceptions of a subject's cognitive and functional abilities Brandao, Paulo
2011
7 4S p. S751-
1 p.
artikel
412 Cannabinoids in neuroinflammation and neurogenesis: From normal aging to Alzheimer's disease models Marchalant, Yannick
2011
7 4S p. S813-
1 p.
artikel
413 Can the KIF6 polymorphism predict statin responsiveness in prodromal and symptomatic Alzheimer's disease? Sabbagh, Marwan
2011
7 4S p. S328-
1 p.
artikel
414 Can we detect Alzheimer's disease 10 years before dementia and why would we want to? Sperling, Reisa
2011
7 4S p. S805-
1 p.
artikel
415 Cardiac effects of rivastigmine patch in elderly patients with Alzheimer disease Isik, Ahmet Turan
2011
7 4S p. S795-S796
2 p.
artikel
416 Cardiac Rehabilitation: Benefits to people with MCI and Alzheimer's disease Middleton, Laura
2011
7 4S p. S614-S615
2 p.
artikel
417 Cardiac surgery accelerates decline in clinical dementia rating scale Evered, Lisbeth
2011
7 4S p. S243-
1 p.
artikel
418 Cardiovascular risk factors are directly correlated with the degree of cognitive decline in Mild cognitive impairment and Alzheimer's disease patients Padurariu, Manuela
2011
7 4S p. S325-
1 p.
artikel
419 Care coordination challenges in the “Last Frontier” Cunningham, Patrick
2011
7 4S p. S774-
1 p.
artikel
420 Caregiver Agreeableness, Neuroticism, Openness and Extraversion Associated with Cognitive Decline in Persons with Alzheimer’s Disease: The Cache County Dementia Progression Study Norton, Maria
2011
7 4S p. S290-
1 p.
artikel
421 Caregiver Burden and Utilization of Social Welfare Services of Elderly Dementia Patients in Korean Long-term Care Insurance System Yeon, Byeong Kil
2011
7 4S p. S631-S632
2 p.
artikel
422 Caregiver burden decreases in women following behavioral intervention for mild cognitive impairment Fields, Julie
2011
7 4S p. e50-
1 p.
artikel
423 Caregiver's interference in performance of mini-mental state examination Buarque, David
2011
7 4S p. S438-S439
2 p.
artikel
424 Caring for a ‘person’ with dementia - prioritising the non-intentional in a caring relationship Greenwood, Dennis
2011
7 4S p. S632-
1 p.
artikel
425 Carnosine (beta-alanyl-L-histidine) treatment ameliorates memory deficits caused by high-fat diet in APPswe/PSEN1dE9 mice Herculano, Bruno
2011
7 4S p. S520-S521
2 p.
artikel
426 Carotenoids and cognitive decline in older women Devore, Elizabeth
2011
7 4S p. S352-
1 p.
artikel
427 Carotid Arterial Plaque and Clinical Factors in Stroke Patients with Dementia Lee, Jun Hong
2011
7 4S p. S171-
1 p.
artikel
428 Catecholamines and Amyloid Murray, Ian
2011
7 4S p. S392-S393
2 p.
artikel
429 Category learning brain potentials as neurocognitive markers for pathologic aging Morrison, Robert
2011
7 4S p. S216-
1 p.
artikel
430 Category learning brain potentials as neurocognitive markers for pathologic aging Morrison, Robert
2011
7 4S p. S32-S33
2 p.
artikel
431 CD200 deletion is associated with increased clearance of Aβ by microglia Lyons, Anthony
2011
7 4S p. e61-
1 p.
artikel
432 Cell cycle aberrations mediate neurotoxicity induced by soluble amyloid-beta oligomers Kudo, Wataru
2011
7 4S p. S406-
1 p.
artikel
433 Cell therapy plus voluntary running rescues memory dysfunction in a rodent model of brain ageing Valenzuela, Michael
2011
7 4S p. e65-e66
nvt p.
artikel
434 Cellular effects of APOE4: Implications for Alzheimer's disease Rao, Rammohan
2011
7 4S p. S569-
1 p.
artikel
435 Cellular models of seeded aggregation of alpha-synuclein and tau Nonaka, Takashi
2011
7 4S p. S116-
1 p.
artikel
436 CERAD memory composite score is an accurate neuropsychological predictor of progression to Alzheimer's disease: AddNeuroMed study Paajanen, Teemu
2011
7 4S p. S259-
1 p.
artikel
437 Cerebellar and cerebral grey and white matter volumes: The Rotterdam Study van der Geest, Jos
2011
7 4S p. S421-
1 p.
artikel
438 Cerebellar and cerebral grey and white matter volumes: The Rotterdam study Hoogendam, Yoo Young
2011
7 4S p. S68-
1 p.
artikel
439 Cerebral amyloid lowering with oral zinc: Removing copper for pennies? Quinn, Joseph
2011
7 4S p. S470-
1 p.
artikel
440 Cerebral artery atherosclerosis is associated with Vascular Dementia, but not with Alzheimer's Disease: A population-based postmortem series Suemoto, Claudia
2011
7 4S p. S305-
1 p.
artikel
441 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and a family with a new Notch3 mutation Zea-Sevilla, M. Ascension
2011
7 4S p. S203-
1 p.
artikel
442 Cerebral haemodynamics, cognitive decline and brain volume change in older patients with type 2 diabetes van den Berg, Esther
2011
7 4S p. S314-
1 p.
artikel
443 Cerebral microbleed detection on 7T MRI: Reliability and effects of image processing de Bresser, Jeroen
2011
7 4S p. S714-
1 p.
artikel
444 Cerebral microbleed detection on 7T MRI: Reliability and effects of image processing de Bresser, Jeroen
2011
7 4S p. S56-S57
2 p.
artikel
445 Cerebral microbleeds are associated with worse cognitive function: The Rotterdam scan study Ikram, M.
2011
7 4S p. S3-
1 p.
artikel
446 Cerebral microbleeds are associated with worse cognitive function: The Rotterdam Scan Study Ikram, Mohammad
2011
7 4S p. S296-
1 p.
artikel
447 Cerebral microbleeds in a phase 2 clinical trial of mild-to-moderate Alzheimer's disease with the gamma secretase inhibitor BMS-708163 Feldman, Howard
2011
7 4S p. S375-
1 p.
artikel
448 Cerebral microinfarcts: A systematic review of neuropathological studies de Bresser, Jeroen
2011
7 4S p. S699-
1 p.
artikel
449 Cerebral structural changes in APP/PS1 mice: A MRI longitudinal study Micotti, Edoardo
2011
7 4S p. S308-
1 p.
artikel
450 Cerebral white matter lesions and the risk of dementia or mild cognitive impairment in the elderly: Influence of premorbid IQ in this relation Mortamais, Marion
2011
7 4S p. S598-S599
2 p.
artikel
451 Cerebrospinal fluid and serum autoantibodies against neurocytoskeletal proteins in patients with Alzheimer's disease Bartos, Ales
2011
7 4S p. S130-
1 p.
artikel
452 Cerebrospinal fluid biomarkers, education, brain volume and future cognition Roe, Catherine M.
2011
7 4S p. S144-
1 p.
artikel
453 Cerebrospinal fluid from patients with Synucleinopathies promotes in vitro -synuclein fibril formation Hirohata, Mie
2011
7 4S p. S753-
1 p.
artikel
454 Cerebrospinal fluid markers of microglial activation and neuroinflammation in Alzheimer's disease Zetterberg, Henrik
2011
7 4S p. S152-
1 p.
artikel
455 Cerebrospinal fluid metabolomics in persons with PSEN1 mutations Ringman, John
2011
7 4S p. S327-
1 p.
artikel
456 Cerebrospinal fluid Orexin A levels in Alzheimer's disease (AD) Marcon, Michela
2011
7 4S p. e14-e15
nvt p.
artikel
457 Cessation versus continuation of 12 months galantamine therapy in patients with Alzheimer's disease: A randomised, double blind, placebo controlled withdrawal trial Adami, Marina
2011
7 4S p. S794-
1 p.
artikel
458 Change in amyloid deposition is related to concurrent cognitive change in MCI Landau, Susan
2011
7 4S p. S28-
1 p.
artikel
459 Change in blood pathology biomarkers to predict Alzheimer's disease: An AIBL 18-month update Doecke, James
2011
7 4S p. S135-
1 p.
artikel
460 Change in plasma beta-amyloid level after glucose loading: A possible biomarker for Alzheimer's disease Sato, Naoyuki
2011
7 4S p. S328-
1 p.
artikel
461 Change in regional cerebral metabolism as a biomarker for dementia conversion Silverman, Daniel
2011
7 4S p. S224-S225
2 p.
artikel
462 Change in the connectivity of multidimensional outcomes in a clinical trial of rosiglitazone for Alzheimer's disease Mitnitski, Arnold
2011
7 4S p. S542-
1 p.
artikel
463 Changes in cerebral blood flow following administration of memantine hydrochloride in Alzheimer's Dementia (DAT) patients - comparative study of spect scan findings using SPM8 Abe, Shine
2011
7 4S p. S378-
1 p.
artikel
464 Changes in cerebral glucose metabolism in early symptomatic frontotemporal dementia linked to chromosome 3 (FTD-3) Johannsen, Peter
2011
7 4S p. S234-
1 p.
artikel
465 Changes in co-prescribing antipsycotics in patients with dementia treated with cholinesterase inhibitors Nobili, Alessandro
2011
7 4S p. S659-S660
2 p.
artikel
466 Changes in eating habits in frontotemporal dementia Iragorri, Angela
2011
7 4S p. S753-
1 p.
artikel
467 Changes in energy metabolism and enhanced oxidative modification of proteins precede phenotype in APP23 mice Hartl, Daniela
2011
7 4S p. S574-S575
2 p.
artikel
468 Changes in glycemic control are associated with changes in cognition in non diabetic elderly Ravona-Springer, Ramit
2011
7 4S p. S600-
1 p.
artikel
469 Changes in hippocampal volume and shape are associated with Alzheimer's disease and other neuropathologies common in the elderly Dawe, Robert
2011
7 4S p. S302-
1 p.
artikel
470 Changes in MRI cortical thickness and [18F]FDG PET data over 24 months in subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Study Charil, Arnaud
2011
7 4S p. S207-
1 p.
artikel
471 Changes in plasma based biomarkers in Alzheimer's disease, mild cognitively impaired and aged matched normal controls from the ADNI cohort Soares, Holly
2011
7 4S p. S329-S330
2 p.
artikel
472 Changes in plasma cytokine levels correlate with clinical outcomes in Alzheimer's patients treated with intravenous immunoglobulin Relkin, Norman
2011
7 4S p. S693-S694
2 p.
artikel
473 Changes in stem-cell maintenance in subventicular zone of rat's brain at Alzheimer's disease pathology and survival effect of embryonal proteoglycans Yenkoyan, Konstantin
2011
7 4S p. S668-
1 p.
artikel
474 Changes in the expression of somatostatin 3 receptor (SSTR3) and p75NTR in the hippocampal primary cilia of Alzheimer's disease transgenic mice Chakravarthy, Balu
2011
7 4S p. S383-
1 p.
artikel
475 Changes in the progression of amyloid deposition in APP/PS mice after overexpression of different ApoE isoforms through intraventricular injection of an adeno-associated virus serotype 4 Hudry, Eloise
2011
7 4S p. S461-S462
2 p.
artikel
476 Changes of biological markers and brain PET imaging and clinical effects of memantine for patients with moderate to severe Alzheimer's disease: A 24-week double-blind, randomized, placebo-controlled study Xiao, Shifu
2011
7 4S p. S298-
1 p.
artikel
477 Changes of functional brain network in mild cognitive impairment and Alzheimer's disease: Graph theoretical analysis of brain glucose metabolism Seo, Eun Hyun
2011
7 4S p. S744-
1 p.
artikel
478 Changes of functional brain network in mild cognitive impairment and Alzheimer's disease: Graph theoretical analysis of brain glucose metabolism Seo, Eun Hyun
2011
7 4S p. S79-
1 p.
artikel
479 Changes of right aI/fO functional connectivity in MCI patients Gang, Qi Zhi
2011
7 4S p. S230-
1 p.
artikel
480 Characterisation of alternative isoforms of TDP-43 D'Alton, Simon
2011
7 4S p. S752-
1 p.
artikel
481 Characterisation of memory function of three APP mutation models of Alzheimer's disease-like pathology Hvoslef-Eide, Martha
2011
7 4S p. S521-
1 p.
artikel
482 Characterising the interaction between tau and metals in rTg4510 mice Adlard, Paul
2011
7 4S p. S479-S480
2 p.
artikel
483 Characteristics and outcome of subjective and mild cognitive impairment in a U.K. memory clinic population Rodda, Joanne
2011
7 4S p. S545-
1 p.
artikel
484 Characteristics of attention/executive function deficits in patients with mild cognitive impairment and sleep apnea syndrome Kang, Kyung-Hun
2011
7 4S p. S248-S249
2 p.
artikel
485 Characteristics of brain morphology in dementia patients from an ADRC Becker, James
2011
7 4S p. S11-
1 p.
artikel
486 Characteristics of mini-mental status examination in subtype of mild cognitive impairment: Using a decision tree analysis Park, Moon Ho
2011
7 4S p. S543-
1 p.
artikel
487 Characteristics of senile cognitive function on multichannel NIRS: Comparison with dementia patients Shoji, Yoshihisa
2011
7 4S p. e39-e41
nvt p.
artikel
488 Characteristics of the longitudinal cognitive profile and accumulation of amyloid-beta protein in Alzheimer's disease patients with or without diabetes mellitus Tomita, Naoki
2011
7 4S p. S607-
1 p.
artikel
489 Characteristics of the self-administered gerocognitive examination (SAGE) used as a screening tool Scharre, Douglas
2011
7 4S p. S166-
1 p.
artikel
490 Characterization and structural determination of the Iowa mutant of Alzheimer's beta-amyloid 22-35 Udad, Xavier
2011
7 4S p. S404-S405
2 p.
artikel
491 Characterization by gender in Alzheimer's disease Cano, Carlos
2011
7 4S p. S439-
1 p.
artikel
492 Characterization in drosophila of TDP-43 physiopathological pathways Miguel, Laëtitia
2011
7 4S p. S524-
1 p.
artikel
493 Characterization of a new ADAM as a key player of the APP metabolism Letronne, Florent
2011
7 4S p. S389-
1 p.
artikel
494 Characterization of different tau isoforms Kampa, Bettina
2011
7 4S p. S555-
1 p.
artikel
495 Characterization of endogenous and exogenous gamma-secretase activating protein (GSAP) expression in cells Hussain, Ishrut
2011
7 4S p. S387-
1 p.
artikel
496 Characterization of flutemetamol binding in autopsy brains from [C-11]PiB imaged subjects Ikonomovic, Milos
2011
7 4S p. S718-
1 p.
artikel
497 Characterization of flutemetamol binding in autopsy brains from [C-11]PiB-imaged subjects Ikonomovic, Milos
2011
7 4S p. S59-
1 p.
artikel
498 Characterization of intrusions in Alzheimer's disease patients using the abridged Boston naming test Bertolucci, Paulo
2011
7 4S p. S276-
1 p.
artikel
499 Characterization of mild cognitive impairment in retired NFL players Randolph, Christopher
2011
7 4S p. S550-
1 p.
artikel
500 Characterization of tau filament assembly with the addition of varying concentrations of ATP and GTP using transmission electron microscopy Farid, Mina
2011
7 4S p. S554-S555
2 p.
artikel
501 Characterization of Tau splicing factors in Alzheimer's disease Adelodun, Aderonke
2011
7 4S p. S561-
1 p.
artikel
502 Characterization of the cortical response to TMS in Alzheimer's disease Casarotto, Silvia
2011
7 4S p. S314-S315
2 p.
artikel
503 Characterizing biomarker dynamics along the Alzheimer's disease trajectory Becker, John
2011
7 4S p. e74-
1 p.
artikel
504 Characterizing individuals who revert from mild cognitive impairment to normal or near-normal cognition Koepsell, Thomas
2011
7 4S p. S539-
1 p.
artikel
505 Chitinase Enzyme Activity in Cerebral Spinal Fluid is Strongly Associated with Alzheimer’s Disease von Arnim, Christine
2011
7 4S p. S288-
1 p.
artikel
506 Cholesterol accumulates in the vicinity of amyloid-beta deposits in brain tissue Solé-Domènech, Santiago
2011
7 4S p. S725-S726
2 p.
artikel
507 Cholesterol and amyloid-beta: Evidence for a cross-talk between astrocytes and neuronal cells Canepa, Elisa
2011
7 4S p. S382-S383
2 p.
artikel
508 Cholesterol and APP Claude potier, Marie
2011
7 4S p. S676-
1 p.
artikel
509 Cholinergic degenerative pathology in ps1m146l/APP751sl alzheimer transgenic model Trujillo-Estrada, Laura
2011
7 4S p. S529-
1 p.
artikel
510 Cholinergic M1 receptor PAM, a promising approach for the treatment of Alzhemer’s Disease Chambon, Caroline
2011
7 4S p. S114-
1 p.
artikel
511 Chronic administration of CHF5074, a novel γ-secretase modulator, prevents brain neurodegeneration in aged Alzheimer's disease transgenic mice Sivilia, Sandra
2011
7 4S p. S520-
1 p.
artikel
512 Chronic treatment with an 11-mer CNTF peptide rescues synaptic deficit and cognitive impairment in a rat model of sporadic Alzheimer's disease Bolognin, Silvia
2011
7 4S p. S794-
1 p.
artikel
513 Chronic treatment with rivastigmine does not modify primary motor cortex synaptic plasticity in patients with Alzheimer's disease (AD): a repetitive transcranial magnetic stimulation (rTMS) study Trebbastoni, Alessandro
2011
7 4S p. e74-
1 p.
artikel
514 Chronic use of benzodiazepines and cognitive decline Mura, Thibault
2011
7 4S p. S692-
1 p.
artikel
515 Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women Blackwell, Terri
2011
7 4S p. S373-
1 p.
artikel
516 3 City Study: An epidemiological study from France Ritchie, Karen
2011
7 4S p. S495-
1 p.
artikel
517 Classical conditioning of the BOLD signal as a paradigm for basic BCI communication in Alzheimer patients Liberati, Giulia
2011
7 4S p. S720-S721
2 p.
artikel
518 Classification of γ-secretase modulators and their effect on pharmacological profiles of amyloid β peptides Xia, Weiming
2011
7 4S p. S476-
1 p.
artikel
519 Clinical and Imaging Correlates of Brain Amyloidosis in Healthy Persons Knopman, David
2011
7 4S p. S1-
1 p.
artikel
520 Clinical and pathologic phenotype of dementia after traumatic brain injury (TBI) Sayed, Nasreen
2011
7 4S p. S753-
1 p.
artikel
521 Clinical applicability of EEG in differential diagnosis of cognitive impairment and dementia Jóhannesson, Gísli Hólmar
2011
7 4S p. S161-
1 p.
artikel
522 Clinical applicability of EEG in evaluating the possibility of a progress of mild cognitive impairment Jóhannesson, Gísli
2011
7 4S p. S538-
1 p.
artikel
523 Clinical, cognitive, neuropsychiatric and genetic predictors of conversion from amnestic mild cognitive impairment to Alzheimer's disease in Chinese older adults Chu, Leung-wing
2011
7 4S p. S349-
1 p.
artikel
524 Clinical correlates of cerebrovascular burden in Alzheimer's disease using a new neuropathological staging system Calais, Gauthier
2011
7 4S p. S699-S700
2 p.
artikel
525 Clinical efficacy of low dose levetiracetam for hippocampal hyperactivity in amnestic mild cognitive impairment Bakker, Arnold
2011
7 4S p. e34-
1 p.
artikel
526 Clinical phenotypic variability in an Italian family bearing the IVS6+5_8delGTGA mutation in PGRN gene Marcon, Gabriella
2011
7 4S p. S163-
1 p.
artikel
527 Clinical trial results showing amelioration of serum zinc deficiency and positive effects on cognitive performance in Alzheimer's and mild cognitive impairment Pollock, Diana
2011
7 4S p. S787-
1 p.
artikel
528 Clinical trial simulation to assess the probabilities of technical success for drugs in Alzheimer's disease proof-of-concept studies Rogers, James
2011
7 4S p. S793-
1 p.
artikel
529 Clinical usefulness of neuropsychological battery for mild dementia Oka, Mizuki
2011
7 4S p. e45-
1 p.
artikel
530 Closed head injury in the guinea pig, a new animal model for Alzheimer's disease? Bates, Kristyn Alissa
2011
7 4S p. S121-
1 p.
artikel
531 CNS cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease Popp, Julius
2011
7 4S p. S395-
1 p.
artikel
532 CNTF peptidergic drugs: A pharmacological approach to enhance neurogenesis, neuronal plasticity and cognition Blanchard, Julie
2011
7 4S p. S490-
1 p.
artikel
533 CNV analysis of Alzheimer's disease GWAS results Wang, Li-San
2011
7 4S p. S85-S86
2 p.
artikel
534 Co-analysis of macro- and microstructural brain alterations in mild cognitive impairment using anatomical and diffusion MRI Cardenas, Valerie
2011
7 4S p. S206-S207
2 p.
artikel
535 Coanalysis of structural imaging and DTI in mild cognitive impairment Cardenas, Valerie
2011
7 4S p. S21-S22
2 p.
artikel
536 Cognitive abilities, well-being and Internet search performance in older people van der Wardt, Veronika
2011
7 4S p. S502-
1 p.
artikel
537 Cognitive aging and cognitive epidemiology in the Lothian Birth Cohorts of 1921 and 1936 Deary, Ian
2011
7 4S p. S484-
1 p.
artikel
538 Cognitive and affective predictors of subjective memory complaints in the Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging: A cross-sectional analysis Buckley, Rachel
2011
7 4S p. S239-
1 p.
artikel
539 Cognitive and CSF biomarkers in older adults, MCI, and dementia Barnett, Jennifer H.
2011
7 4S p. S129-S130
2 p.
artikel
540 Cognitive and socioeconomic predictors of survival in dementia Russ, Tom
2011
7 4S p. S601-
1 p.
artikel
541 Cognitive-behavioral treatment for mild alzheimer's patients and their caregivers (CBTAC): A case study of a comprehensive treatment approach Forstmeier, Simon
2011
7 4S p. S492-
1 p.
artikel
542 Cognitive behavioral treatment of anxiety in mild to moderate dementia Wilson, Nancy
2011
7 4S p. S279-
1 p.
artikel
543 Cognitive decline and defects in neuroplasticity are reversible in an inducible mouse model expressing pro-aggregant full-length human tau Hochgraefe, Katja
2011
7 4S p. S505-
1 p.
artikel
544 Cognitive decline and depression in 29 U.S. Alzheimer's disease centers Hermida, Adriana
2011
7 4S p. S352-S353
2 p.
artikel
545 Cognitive deficits in cancer patients: How to evaluate? Bottino, Sara
2011
7 4S p. S551-S552
2 p.
artikel
546 Cognitive dysfunction in patients with folate deficiency Shirafuji, Norimichi
2011
7 4S p. S789-
1 p.
artikel
547 Cognitive function in African-American versus white women of similar educational attainment and healthcare access Devore, Elizabeth
2011
7 4S p. e51-
1 p.
artikel
548 Cognitive function in a multi-ethnic population from Singapore Ikram, Mohammad Kamran
2011
7 4S p. S693-
1 p.
artikel
549 Cognitive function in asymptomatic carriers of presenilin-1 mutations Bosch, Beatriz
2011
7 4S p. S238-
1 p.
artikel
550 Cognitive function in multiple system atrophy-C (cerebellar type) Kwon, Yooseok
2011
7 4S p. S758-
1 p.
artikel
551 Cognitive impairment and MRI findings in community dwelling Chinese Hilal, Saima
2011
7 4S p. S354-
1 p.
artikel
552 Cognitive impairment and oral health in older adults Wu, Bei
2011
7 4S p. S368-
1 p.
artikel
553 Cognitive impairment in postmenopausal women Bojar, Iwona
2011
7 4S p. S246-
1 p.
artikel
554 Cognitive impairment moderates the relationship between social capital and self-perceived health Wang, Jye
2011
7 4S p. e53-
1 p.
artikel
555 Cognitive Impairment: On-Line Tutorial to Choose the Right Screening Tools Subara, Danijela
2011
7 4S p. S170-S171
2 p.
artikel
556 Cognitive improvement and anti-amyloidogenic effect of doxycycline in a double transgenic mouse model of Alzheimer disease Balducci, Claudia
2011
7 4S p. S459-
1 p.
artikel
557 Cognitive intervention in Alzheimer's disease: a treatment option to consider? Alves, Jorge
2011
7 4S p. e44-
1 p.
artikel
558 Cognitive intervention in a variant of Alzheimer's disease: A case report Alves, Jorge
2011
7 4S p. e44-
1 p.
artikel
559 Cognitively normal individuals with Alzheimer's disease parents may be at risk for developing aging-related cortical thinning patterns characteristic of Alzheimer's disease Reiter, Katherine
2011
7 4S p. S227-S228
2 p.
artikel
560 Cognitive profile of symptomatic CADASIL patients without cognitive complaint Lee, Jung Seok
2011
7 4S p. S758-
1 p.
artikel
561 Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition Vemuri, Prashanthi
2011
7 4S p. S80-S81
2 p.
artikel
562 Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition Vemuri, Prashanthi
2011
7 4S p. S149-
1 p.
artikel
563 Cognitive stimulation in elderly people Apostolo, Joao
2011
7 4S p. S444-S445
2 p.
artikel
564 Cognitive tests sensitive to cholinesterase inhibitor treatment for Alzheimer's disease Clifford, Angela
2011
7 4S p. S449-S450
2 p.
artikel
565 Cognitive Training Smith, Glenn E.
2011
7 4S p. S88-
1 p.
artikel
566 Cognitive training on elderly japanese in osaka: Major outcome (ADAS) from prospective, randomized, open, blind-endpoint trial Hayashi, Noriyuki
2011
7 4S p. S644-
1 p.
artikel
567 Cognitive ztimulation during hospitalization improves global cognition of older Taiwanese patients Chen, Cheryl Chia-Hui
2011
7 4S p. S642-
1 p.
artikel
568 Co-localization of heparan sulfate proteoglycans with the amyloid beta protein in APPswe/PS1dE9 mice is limited Timmer, Nienke
2011
7 4S p. S529-
1 p.
artikel
569 Combination of cerebral metabolic and cognitive information as a better predictor of the conversion to Alzheimer's disease in mild cognitive impairment: A two-year follow-up study Lee, Dong Young
2011
7 4S p. S215-
1 p.
artikel
570 Combination of cerebral metabolic and cognitive information as a better predictor of the conversion to Alzheimer's disease in mild cognitive impairment: A two-year follow-up study Lee, Dong Young
2011
7 4S p. S29-
1 p.
artikel
571 Combination of novel α7 Nicotinic acetylcholine receptor agonists with existing alzheimer's treatments van Goethem, Nick
2011
7 4S p. S773-
1 p.
artikel
572 Combination training increases cognitive performances and modifies the brain resting state activity of healthy aging individuals Esposito, Roberto
2011
7 4S p. S420-
1 p.
artikel
573 Combined dietary vitamins B6, B12, and folic acid increase plasma choline levels in rats van Wijk, Nick
2011
7 4S p. S666-
1 p.
artikel
574 Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion Westman, Eric
2011
7 4S p. e16-
1 p.
artikel
575 Combining predictive markers of cognitive decline in MCI: Cost-benefit analysis Thiele, Frank
2011
7 4S p. S546-S547
2 p.
artikel
576 Communication toolkit: Environmental interventions for dementia Brush, Jennifer
2011
7 4S p. S629-
1 p.
artikel
577 Comparing facial emotion processing in progressive nonfluent aphasia, logopenic progressive aphasia and Alzheimer's disease Piguet, Olivier
2011
7 4S p. S163-S164
2 p.
artikel
578 Comparing Global measures of cognitive decline in amnestic mci subjects in the National Alzheimer's Coordinating Center (NACC) uniform data set Monsell, Sarah
2011
7 4S p. S542-S543
2 p.
artikel
579 Comparing the gene expression patterns in blood from subjects with stable mild cognitive impairment vs. subjects converting to Alzheimer's disease Roed, Line
2011
7 4S p. S327-
1 p.
artikel
580 Comparison between four different neuroimaging tools to evaluate thalamus and corpus callosum anatomy in mild Alzheimer's disease Balthazar, Marcio
2011
7 4S p. S54-
1 p.
artikel
581 Comparison of apraxia severity of dementia syndromes Özbabalik, Demet
2011
7 4S p. S767-
1 p.
artikel
582 Comparison of clinical and neuropathological definitions of alzheimer's disease at national institute on aging Alzheimer's disease centers, 2005-2010 Beach, Thomas
2011
7 4S p. S532-S533
2 p.
artikel
583 Comparison of diagnostic power of cerebrospinal fluid Aß and Tau variables for Alzheimer's disease diagnosis: proposition of a simple decision tree Schraen-Maschke, Susanna
2011
7 4S p. S145-
1 p.
artikel
584 Comparison of efficacy and side effects between Aripiprazole and Haloperidol in the treatment of delirium Park, SangJin
2011
7 4S p. e62-
1 p.
artikel
585 Comparison of [F-18] flutemetamol PET imaging and MTA measures in Alzheimer disease Duara, Ranjan
2011
7 4S p. S716-
1 p.
artikel
586 Comparison of Japanese and Chinese student's perception to the person with dementia Kobayashi, Ryuji
2011
7 4S p. S440-
1 p.
artikel
587 Comparison of measurements of medial temporal lobe atrophy in the prediction of Alzheimer's Disease in subjects with MCI Clerx, Lies
2011
7 4S p. S133-
1 p.
artikel
588 Comparison of multiple neuropsychological models to predict amyloid deposition England, Rebecca
2011
7 4S p. S243-
1 p.
artikel
589 Comparison of placebo responses in Alzheimer's disease clinical trials Ito, Kaori
2011
7 4S p. e72-
1 p.
artikel
590 Comparison of profiles of cognitive domain impairment on the MOCA and MMSE in an elderly versus a CVD population in a research setting Markwick, Arwen
2011
7 4S p. S536-
1 p.
artikel
591 Comparison of statistical approaches to optimize scoring of participant/informant reports to predict future dementia Rabin, Laura
2011
7 4S p. S261-
1 p.
artikel
592 Comparison of statistical models estimating rate of decline in a population-based cohort of persons with Alzheimer's disease: The Cache County study Tripodis, Yorghos
2011
7 4S p. S602-
1 p.
artikel
593 Comparison of the back-to-back reproducibility of the Siena/FSL whole brain atrophy measurement at 3T and 1.5T using the ADNI MPRAGE MRIs Cover, Keith
2011
7 4S p. S65-S66
2 p.
artikel
594 Comparison of the International Working Group criteria and NIA-AA criteria for the prediction of Alzheimer's-type dementia in subjects with MCI Visser, Pieter Jelle
2011
7 4S p. e20-e21
nvt p.
artikel
595 Comparison of two verbal memory tests for the diagnosis and predictive value of MCI Silva, Dina
2011
7 4S p. S266-
1 p.
artikel
596 Comparison of verbal episodic memory measures: Consortium to establish a registry for Alzheimer's disease - neuropsychological assessment battery (CERAD-NAB) vs. California verbal learning test (CVLT) Beck, Irene
2011
7 4S p. S238-
1 p.
artikel
597 Complement Activation in Alzheimer’s Disease Visser, Pieter Jelle
2011
7 4S p. S288-S289
2 p.
artikel
598 Complement components C5-derived C5a anaphylatoxin-mediated attenuation of cognitive deterioration is a potential novel pharmacological target of IVIG regulated hormonal immunotherapy in Alzheimer's disease Pasinetti, Giulio
2011
7 4S p. S670-
1 p.
artikel
599 Complexes of amyloid β and Amyloid-β-crystallin as potential biomarkers for early stage Alzheimer's disease Bruggink, Kim
2011
7 4S p. S131-
1 p.
artikel
600 Compliance of patients with Alzheimer's disease to treatment with transdermal rivastigmine and its effectiveness and tolerability in daily practice Adler, Georg
2011
7 4S p. S776-
1 p.
artikel
601 Composite cognitive endpoints with improved power to detect presymptomatic Alzheimer's disease treatment effects: Findings in the Colombian kindred with the E280A Presenilin 1 mutation and the Alzheimer's Prevention Initiative Ayutyanont, Napatkamon
2011
7 4S p. S608-
1 p.
artikel
602 Composite cognitive endpoints with improved power to detect presymptomatic Alzheimer's disease treatment effects in APOE4 carriers: Findings from the Alzheimer's prevention initiative Langbaum, Jessica
2011
7 4S p. S502-
1 p.
artikel
603 Composite scores for memory outperformed other approaches to the neuropsychological data collected by the Alzheimer's Disease Neuroimaging Initiative (ADNI) Gibbons, Laura
2011
7 4S p. S245-S246
2 p.
artikel
604 Comprehensive neuropsychological assessment can differentiate between adults with MCI who develop Alzheimer's dementia from those who recover Summers, Mathew
2011
7 4S p. S683-
1 p.
artikel
605 Comprehensive Variant Discovery in the Late-Onset Alzheimer’s Disease Susceptibility Gene MTHFD1L Using Next Generation Sequencing Technology Kohli, Martin
2011
7 4S p. S188-
1 p.
artikel
606 Computational and experimental elucidation of Amyloid-Beta oligomerization and its biological effects Teplow, David
2011
7 4S p. S400-
1 p.
artikel
607 Computer simulation of four key IADLs distinguishes cognitively impaired from unimpaired older adults Rapp, Steve
2011
7 4S p. S164-
1 p.
artikel
608 Concentration of rivastigmine and its metabolite to the therapeutic response in Alzheimer's disease Yang, Yuan-Han
2011
7 4S p. S667-
1 p.
artikel
609 Concepts of Preclinical Dementias Dubois, Bruno
2011
7 4S p. S280-
1 p.
artikel
610 Conformational intrabodies targeting subcellular Aβ oligomers Meli, Giovanni
2011
7 4S p. S391-
1 p.
artikel
611 Conformation directed immunomodulation targeting amyloid plaques, CAA and neurofibrillary tangle pathology in model mice Goni, Fernando
2011
7 4S p. e67-e68
nvt p.
artikel
612 Consistent Staff Assignment in Alzheimer’s Special Care Units Castle, Nicholas
2011
7 4S p. S292-
1 p.
artikel
613 Constrained spherical deconvolution based tractography and cognition in Alzheimer's disease Reijmer, Yael
2011
7 4S p. S724-
1 p.
artikel
614 Consumption of hydrogen water prevents age-dependent memory impairment accompanying neurodegeneration in Alzheimer's model mice Ohsawa, Ikuroh
2011
7 4S p. S660-
1 p.
artikel
615 Contents 2011
7 4S p. A3-A6
nvt p.
artikel
616 Content validity and acceptability of the daily enhancement of meaningful activity program Haase, Joan
2011
7 4S p. S624-
1 p.
artikel
617 Contrasting default mode abnormalities in Alzheimer's disease revealed by task and passive rest Schwindt, Graeme
2011
7 4S p. S223-S224
2 p.
artikel
618 Contrasting default mode abnormalities in Alzheimer's disease revealed by task and passive rest Schwindt, Graeme
2011
7 4S p. S37-
1 p.
artikel
619 Contribution of executive functioning and memory to rule induction in healthy older people and patients with MCI or early dementia Heringa, Sophie
2011
7 4S p. S247-
1 p.
artikel
620 Contribution of genetic and dietary insulin resistance to Alzheimer’s phenotype in APP/PS1 transgenic mice Hiltunen, Mikko
2011
7 4S p. S98-S99
2 p.
artikel
621 Conversion from mild cognitive impairment to Alzheimer's disease over 12 months: Predictive value of Aβ imaging with 18F-Florbetaben Ong, Kevin
2011
7 4S p. S33-
1 p.
artikel
622 Conversion from mild cognitive impairment to Alzheimer's disease over 12 months: Predictive value of Aβ imaging with 18F-Florbetaben Ong, Kevin
2011
7 4S p. S217-
1 p.
artikel
623 Coping strategies may vary according to working memory performance in individuals with Alzheimer's disease Souza-Talarico, Juliana
2011
7 4S p. S626-
1 p.
artikel
624 Cornel iridoid glycoside improves memory ability and microenvironment for central nerve regeneration in fimbria-fornix transected rats Li, Lin
2011
7 4S p. S797-S798
2 p.
artikel
625 Coronary risk correlates with cerebral amyloid deposition in non demented elders Reed, Bruce
2011
7 4S p. S301-
1 p.
artikel
626 Corrected cerebral flow reserve as a marker of dementia risk Pretorius, Harold
2011
7 4S p. S663-
1 p.
artikel
627 Corrected Cerebral Flow Reserve from Brain SPECT as a Marker of Dementia Risk Pretorius, Harold
2011
7 4S p. S45-
1 p.
artikel
628 Correction of bias in estimating rate of cognitive decline using auxiliary telephone cognitive evaluation data Wang, Cuiling
2011
7 4S p. S272-S273
2 p.
artikel
629 Correlates of cerebrospinal fluid neurotransmitter alterations with behavioral disturbances in dementia Vermeiren, Yannick
2011
7 4S p. S765-S766
2 p.
artikel
630 Correlating imaging with language impairment in degenerative dementias: How well do PIB and FDG-PET match behavior? Chertkow, Howard
2011
7 4S p. S12-
1 p.
artikel
631 Correlating imaging with language impairment in degenerative dementias: How well do PIB and FDG PET match behavior? Chertkow, Howard
2011
7 4S p. S338-
1 p.
artikel
632 Correlation between atrial fibrillation, stroke and dementia Baidac, Gratiela
2011
7 4S p. S369-S370
2 p.
artikel
633 Correlation between baseline measures of amyloid-positron emission tomography (PET) imaging, cerebral spinal fluid (CSF) biomarkers, and clinical scales in predementia Alzheimer's disease Coric, Vlad
2011
7 4S p. S209-
1 p.
artikel
634 Correlation between CSF amyloid beta 1-42 and plasma glucose/insulin is modulated by ApoE4 polymorphism in early onset sporadic Alzheimer's disease (EOAD). La Sala, Angela
2011
7 4S p. S321-
1 p.
artikel
635 Correlation between loss of perfusion and vascular amyloidosis in transgenic mouse models of Alzheimer's Disease assessed with multi-functional PET/MR Maier, Florian
2011
7 4S p. S307-S308
2 p.
artikel
636 Correlation between neuropsychiatric syndromes and impaired activities of daily living in a community-based sample of patients with dementia Folquitto, Jefferson
2011
7 4S p. S623-
1 p.
artikel
637 Correlation between serum brain-derived neurotrophic factor and verbal fluency Camozzato, Analuiza
2011
7 4S p. S533-
1 p.
artikel
638 Correlation of cognitive deficits and brain cholinesterase activity in streptozotocin-intracerebroventricularly treated rat model of sporadic alzheimer's disease Petrisic, Melita Salkovic
2011
7 4S p. S125-S126
2 p.
artikel
639 Correlation of white matter lesions with lacunar infarcts in patients with mixed Alzheimer's disease with subcortical vascular lesion Kim, Heeyoung
2011
7 4S p. e75-e76
nvt p.
artikel
640 Correlations between amyloid and metabolic pet imaging in cognitively normal adults with a family history of late-onset Alzheimer's disease Cummings, Megan
2011
7 4S p. S209-S210
2 p.
artikel
641 Correlations between clinical symptoms and biochemistry in lewy body dementia and Parkinson's disease dementia Whitfield, David
2011
7 4S p. S766-
1 p.
artikel
642 Correlations between functional connectivity, structural brain volume, and episodic memory in cognitively normal older adults He, Jing
2011
7 4S p. S420-S421
2 p.
artikel
643 Correlations of Clinical and Imaging Aspects in Alzheimer’s and Mixed Dementia Petrescu, Alice
2011
7 4S p. S175-
1 p.
artikel
644 Correlations of magnetic resonance spectroscopy with cognitive Function in remitted late-life major depressive disorder Chen, Cheng-Sheng
2011
7 4S p. S231-
1 p.
artikel
645 Correlations of prefrontal cortical activation and cognitive performance with therapeutic cholinesterase inhibitor treatment: A high-field functional magnetic resonance imaging study Song, Xiaowei
2011
7 4S p. S377-
1 p.
artikel
646 Cortical amyloid deposition and glucose metabolism in clinically different stages of Alzheimer's disease Hatashita, Shizuo
2011
7 4S p. S748-
1 p.
artikel
647 Cortical atrophy rates in Alzheimer's disease and mild cognitive impairment from the ADNI study Spenger, Christian
2011
7 4S p. S225-
1 p.
artikel
648 Cortical connectivity and sensory binding: A neurocognitive approach to the detection and assessment of Alzheimer's disease Heindel, William
2011
7 4S p. S673-
1 p.
artikel
649 Cortical signature of Alzheimer's disease-related thinning in presymptomatic presenilin-1 mutation carriers Quiroz, Yakeel
2011
7 4S p. S220-
1 p.
artikel
650 Cortical signature of alzheimer's disease-related thinning in presymptomatic presenilin-1 mutation carriers Quiroz, Yakeel
2011
7 4S p. S7-
1 p.
artikel
651 Cortical thickness comparison between PiB-positive and PiB-negative healthy control patients Dore, Vincent
2011
7 4S p. S210-S211
2 p.
artikel
652 Cortical thickness estimation accuracy with three automated algorithms Redolfi, Alberto
2011
7 4S p. S723-S724
2 p.
artikel
653 Cortical thinning in early vs. Late-onset alzheimer’s disease: brain-behavior relationships and genetic Influences Dickerson, Bradford
2011
7 4S p. S90-
1 p.
artikel
654 Cost-effectiveness of donepezil 23 mg in the treatment of moderate to severe Alzheimer's disease from a US payor perspective Knoth, Russell
2011
7 4S p. S797-
1 p.
artikel
655 Course of depression in mild dementia Fritze, Friederike
2011
7 4S p. S159-
1 p.
artikel
656 Creating cognitive prostheses for people with Alzheimer's disease Ellis, Maggie
2011
7 4S p. S628-S629
2 p.
artikel
657 Creutzfeld-Jakob disease: Is it possible to detect a neuropsychological profile? Carlesi, Cecilia
2011
7 4S p. S751-S752
2 p.
artikel
658 Criteria Justifying Screening Beyond the Research Context Rockwood, Kenneth
2011
7 4S p. S281-S282
2 p.
artikel
659 Critical analysis of road test designs for older drivers with cognitive impairment Ott, Brian
2011
7 4S p. S442-
1 p.
artikel
660 Cross cultural validation of a dementia screening test Hogervorst, Eef
2011
7 4S p. S160-S161
2 p.
artikel
661 CRP and depressive symptoms in Alzheimer's disease Hall, James
2011
7 4S p. S246-
1 p.
artikel
662 CSF and MRI biomarkers as predictors for Alzheimer's-type dementia in subjects with mild cognitive impairment Vos, Stephanie
2011
7 4S p. S107-
1 p.
artikel
663 CSF Aβ peptides in neuropathologically diagnosed dementias with lewy bodies and Alzheimer's type Bibl, Mirko
2011
7 4S p. S153-
1 p.
artikel
664 CSF Aβ42 reduction in cognitively intact elderly individuals with major depressive disorder Pomara, Nunzio
2011
7 4S p. S326-
1 p.
artikel
665 CSF biomarker and PIB-PET—derived beta-amyloid signature predicts Brain metabolism, grey matter and cognitive changes in non-demented subjects Ewers, Michael
2011
7 4S p. S102-
1 p.
artikel
666 CSF biomarker and PIB-PET–derived beta-amyloid signature predicts metabolic, grey matter and cognitive changes in nondemented subjects Ewers, Michael
2011
7 4S p. S4-
1 p.
artikel
667 CSF biomarker cut-offs for the diagnosis of Alzheimer's disease in a memory clinical center Dumurgier, Julien
2011
7 4S p. S135-S136
2 p.
artikel
668 CSF biomarker is useful for differential diagnosis of Alzheimer disease (AD) and dementia with Lewy bodies (DLB); An autopsy- confirmed study Morimoto, Satoru
2011
7 4S p. S323-S324
2 p.
artikel
669 CSF biomarker levels in early and classic onset of Alzheimer's disease Stefanova, Elka
2011
7 4S p. S330-
1 p.
artikel
670 CSF biomarker qualification Soares, Holly
2011
7 4S p. S810-
1 p.
artikel
671 CSF biomarkers and cognitive decline in Alzheimer's disease patients Merlin, Béatrice
2011
7 4S p. S326-
1 p.
artikel
672 CSF biomarkers predict progression in patients with subjective memory complaints van Harten, Argonde
2011
7 4S p. S102-
1 p.
artikel
673 CSF, MRI, and APOE biomarkers as predictors for Alzheimer-type dementia in subjects with amnestic versus non-amnestic mild cognitive impairment Vos, Stephanie
2011
7 4S p. S548-S549
2 p.
artikel
674 CSF Neurotransmitter Metabolites and Brain-Specific Proteins Differentiate Dementia with Lewy Bodies from Alzheimer’s Verbeek, Marcel
2011
7 4S p. S290-
1 p.
artikel
675 CSF Phosphorylated tau and Aβ In Seven FAD cases with different PSEN1 mutations Ikeda, Masaki
2011
7 4S p. S579-
1 p.
artikel
676 CSF sPLA2 activity: A new biomarker of Neuroinflammation and Blood-CSF barrier impairment Chalbot, Sonia
2011
7 4S p. S675-S676
2 p.
artikel
677 C-terminal TDP-43 inclusion suppresses proliferation mediated by transcriptional dysregulation Yamashita, Makiko
2011
7 4S p. S118-S119
2 p.
artikel
678 Cultivation of adult organotypic brain slices from P301S mice Mewes, Agneta
2011
7 4S p. S524-
1 p.
artikel
679 Cultural and genetic factors related to frontotemporal dementia Cano, Carlos
2011
7 4S p. S439-
1 p.
artikel
680 Curcumin derivatives for amyloid detection using 19F magnetic resonance imaging Taguchi, Hiroyasu
2011
7 4S p. S311-
1 p.
artikel
681 Curcumin has binding activity to β-amyloid oligomer Yanagisawa, Daijiro
2011
7 4S p. S476-S477
2 p.
artikel
682 Curcumin protects cultured rat cortical neurons from Aβ-Induced damage by depressing intracellular reactive oxygen species Huang, Han-Chang
2011
7 4S p. S403-S404
2 p.
artikel
683 Cyclic PDZ-binding peptides as neuroprotective agents against excitotoxic brain damage Austen, Brian
2011
7 4S p. S648-S649
2 p.
artikel
684 Cyclin-dependent Kinase 5 (CDK5) and cyclins in the mechanism of cell degeneration and death: Implications for Alzheimer's disease Czapski, Grzegorz
2011
7 4S p. S581-S582
2 p.
artikel
685 Cytokine Up-Regulation as a Contributor to CNS Pathophysiology Van Eldik, Linda
2011
7 4S p. S286-
1 p.
artikel
686 D2 dopamine recepter (DRD2) gene polymorphism and combat-related posttraumatic stress disorder in Vietnam veterans Choi, Jinhee
2011
7 4S p. S203-
1 p.
artikel
687 Decaffeinated coffee promotes successful aging through epigenetic modifications associated with promotion of mitochondrial energy metabolism in the brain Pasinetti, Giulio
2011
7 4S p. S662-
1 p.
artikel
688 Decline in mitochondrial bioenergetics underlies central insulin resistance in streptozocin-induced model of sporadic Alzheimer's disease Correia, Sónia
2011
7 4S p. S562-
1 p.
artikel
689 Decline in tau levels from antisense oligo treatment: A potential curative mechanism for Alzheimer's disease Sud, Reeteka
2011
7 4S p. e65-
1 p.
artikel
690 Declines in entorhinal cortex structural connectivity in amnestic mild cognitive impairment Rowley, Jared
2011
7 4S p. S36-
1 p.
artikel
691 Declines of vestibular function are associated with brain atrophy and cognitive impairment Lee, Geun-Ho
2011
7 4S p. e19-
1 p.
artikel
692 Deconstructing language disintegration: Primary progressive aphasias have specific tractographic signatures Mahoney, Colin
2011
7 4S p. S758-S759
2 p.
artikel
693 Deconstructing language disintegration: Primary progressive aphasias have specific tractographic signatures Mahoney, Colin
2011
7 4S p. S16-S17
2 p.
artikel
694 Decreased axonal transport during Alzheimer's-like spatial-temporal tau pathology leads to imbalance of NGF, cholinergic dysfunction, and decreased regulation of BDNF and TrkB Zimmermann, Katharina Schindowski
2011
7 4S p. S560-S561
2 p.
artikel
695 Decreased levels of serum antibodies against different tau antigens in patients with Alzheimer disease Bartos, Ales
2011
7 4S p. S130-
1 p.
artikel
696 Decreased rabphilin 3A immunoreactivity in Alzheimer's disease neocortex Lai, Mitchell
2011
7 4S p. S703-
1 p.
artikel
697 Decrease in event-related EEG coherence in Alzheimer's patients during an episodic memory paradigm Morison, Gordon
2011
7 4S p. S739-
1 p.
artikel
698 Decrease of PTEN expression levels among normal, symptomatic and asymptomatic Alzheimer's disease (Ad) subjects, measured in hippocampus, temporal and entorhinal cortices. Feio dos Santos, Ana Cecília
2011
7 4S p. S701-
1 p.
artikel
699 Deep subcortical white matter disease is a major risk factor for late post stroke cognitive impairment Kandiah, Nagaendran
2011
7 4S p. S755-S756
2 p.
artikel
700 Default mode network in patients with Parkinson's disease dementia Rektorova, Irena
2011
7 4S p. S220-S221
2 p.
artikel
701 Degradation in microstructural uniformity of the cingulum fiber bundle in MCI and Alzheimer's disease Zhang, Yu
2011
7 4S p. S65-
1 p.
artikel
702 Degradation in microstructural uniformity of the cingulum fiber bundle in Mild Cognitive Impairment and Alzheimer's Disease Zhang, Yu
2011
7 4S p. S728-S729
2 p.
artikel
703 Dementia after Age 90: Prevalence and risk factors in a longitudinal study Whitmer, Rachel
2011
7 4S p. S602-S603
2 p.
artikel
704 Dementia and depression: Two existing comorbidities Manvelyan, Hovhannes
2011
7 4S p. S162-S163
2 p.
artikel
705 Dementia and mortality in advancing age Jacobs, Jeremy
2011
7 4S p. S603-
1 p.
artikel
706 Dementia and the obesity paradox Beckett, Nigel
2011
7 4S p. e8-
1 p.
artikel
707 Dementia care in family practices in Germany: primary data on figures and attitudes Thyrian, Jochen René
2011
7 4S p. S636-
1 p.
artikel
708 Dementia in idiopathic normal pressure hydrocephalus: Kuopio NPH study Koivisto, Anne
2011
7 4S p. S756-
1 p.
artikel
709 Dementia in Pakistan: initial results from our registry at a tertiary care hospital Ahmad, Arsalan
2011
7 4S p. S767-
1 p.
artikel
710 Dementia prevalence in an indigenous population from Brazilian amazon Caixeta, Leonardo
2011
7 4S p. S604-
1 p.
artikel
711 Dementia Screening in Low Education Populations: Results from the Kerala-Einstein Study Verghese, Joe
2011
7 4S p. S168-
1 p.
artikel
712 Dementia symptom profiles in relation to stage Rockwood, Kenneth
2011
7 4S p. S544-
1 p.
artikel
713 Denaturing High Performance Liquid Chromatography (dHPLC) Screening to Find Out Genetic Polymorphisms in the Sirtuin Gene Family Relevant for Alzheimer’s Disease Susceptibility Albani, Diego
2011
7 4S p. S192-
1 p.
artikel
714 Dependence and resource utilization in MCI and Alzheimer’s patients participating in the AIBL study Ellis, Kathryn
2011
7 4S p. S439-S440
2 p.
artikel
715 Depression and serotonin 5-HT4 receptor binding in Alzheimer's disease Hasselbalch, Steen
2011
7 4S p. S735-S736
2 p.
artikel
716 Depression, falls and cognitive changes among community-dwelling elderly people Aharony, Lea
2011
7 4S p. S622-
1 p.
artikel
717 Depression history, depressive symptoms and incident dementia: The 3C study Lenoir, Hermine
2011
7 4S p. S355-S356
2 p.
artikel
718 Depression in the mild behavioral impairment (MBI), mild cognitive impairment (MCI), Alzheimer's disease (AD) spectrum: Priorities for clinical and neurobiological research Smith, Gwenn
2011
7 4S p. S91-S92
2 p.
artikel
719 Depression is not associated to increased [11C]PIB-PET levels Madsen, Karine
2011
7 4S p. S31-
1 p.
artikel
720 Depression predicts progressive brain atrophy in mild cognitive impairment Lee, Grace
2011
7 4S p. S28-S29
2 p.
artikel
721 Depression predicts progressive brain atrophy in mild cognitive impairment Lee, Grace
2011
7 4S p. S215-
1 p.
artikel
722 Deregulation of AMPK activation in Alzheimer's disease and other tauopathies Vingtdeux, Valerie
2011
7 4S p. S557-S558
2 p.
artikel
723 Descriptive analysis of caregiving network in dementia patients in the province of Alicante, Spain. Who looks after the caregiver? Martinez, Vicente Medrano
2011
7 4S p. S432-
1 p.
artikel
724 Descriptive analysis of dementia caregivers in the province of Alicante Spain: main characteristics of the principal caregiver. Toribio-Diaz, Elena
2011
7 4S p. S435-
1 p.
artikel
725 Design considerations for presymptomatic clinical trials: The Alzheimer's prevention initiative perspective Tariot, Pierre
2011
7 4S p. S807-
1 p.
artikel
726 Dessgn and methods of antipsychotic dicontinuation in Alzheimer's disease (ADAD) study Devanand, Davangere
2011
7 4S p. S642-S643
2 p.
artikel
727 Detecting and characterizing complex behavioral symptoms of persons with dementia Woods, Lynn
2011
7 4S p. e53-e54
nvt p.
artikel
728 Detection of Alzheimer's disease using quantitative MRI-based measures Zhu, David
2011
7 4S p. S27-
1 p.
artikel
729 Detection of an ‘Alzheimer's type’ memory profile in mild cognitive impairment Siders, Craig
2011
7 4S p. S270-
1 p.
artikel
730 Detection of APL-1β peptides from normal and Alzheimer's tissue/plasma samples Chang, Jaw-Kang
2011
7 4S p. S132-
1 p.
artikel
731 Detection of tissue transglutaminase with new antibodies in immunohistochemistry Jäger, Carsten
2011
7 4S p. S320-
1 p.
artikel
732 Determinants of survival in autopsy-confirmed patients with behavioral variant frontotemporal dementia (bvFTD): Second Report of the international bvFTD criteria consortium (FTDC) Rascovsky, Katya
2011
7 4S p. S761-S762
2 p.
artikel
733 Determining rate of decline in pre-Alzheimer's and Alzheimer's Disease AIBL participants using a regular brief cognitive assessment Maruff, Paul
2011
7 4S p. S255-
1 p.
artikel
734 Determonistic vs. probabilistic: Two-tensor tractography of the cingulate bundle in healthy aging Fischer, Florian
2011
7 4S p. S420-
1 p.
artikel
735 Developing and validating of Diagnostic Algorithm for Alzheimer's Disease Xiao, Guanghua
2011
7 4S p. S334-S335
2 p.
artikel
736 Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain Li, Xiaojing
2011
7 4S p. S409-
1 p.
artikel
737 Development of a clinical risk score for predicting dementia in the DESCRIPA project (European pooled data base) and validation in the three-city study Artero, Sylvaine
2011
7 4S p. S591-
1 p.
artikel
738 Development of a composite score of the German CERAD-Plus-Neuropsychological assessment battery Schmid, Nicole
2011
7 4S p. S258-
1 p.
artikel
739 Development of AFFITOPE Alzheimer vaccines: Results of phase I studies with AD01 and AD02 Mandler, Markus
2011
7 4S p. S793-
1 p.
artikel
740 Development of a genetic education and genetic risk disclosure protocol for individuals with mild cognitive impairment Lautenbach, Denise
2011
7 4S p. S95-
1 p.
artikel
741 Development of an Alzheimer's disease mouse model using viral vectors to cause localized over-expression of beta amyloid Drummond, Eleanor
2011
7 4S p. S122-
1 p.
artikel
742 Development of a novel beta amyloid vaccine to treat Alzheimer's disease Vigo, Carmen
2011
7 4S p. e66-e67
nvt p.
artikel
743 Development of a novel proteomic approach for the unbiased identification of nitrated proteins in Alzheimer's disease brains Nuriel, Tal
2011
7 4S p. e32-
1 p.
artikel
744 Development of a rodent-specific ELISA and delipidation method for accurate measurement of apoE levels in the CSF Maxwell, Jill
2011
7 4S p. S334-
1 p.
artikel
745 Development of a single antisense to APP and PS-1 Morley, John
2011
7 4S p. S572-
1 p.
artikel
746 Development of DNA aptamers that bind to amyloid oligomers Tsukakoshi, Kaori
2011
7 4S p. S331-
1 p.
artikel
747 Development of Feeding Difficulty Index (FDI) and establishment of the validity and reliability Chang, Chia-Chi
2011
7 4S p. S449-
1 p.
artikel
748 Development of highly accurate measurements of Aβ using formic acid Nanjo, Toshifumi
2011
7 4S p. S143-
1 p.
artikel
749 Development of preclinical models of vasogenic edema (VE) and microhemorrhage (MCH) using in-vivo bioimaging and histopathology Freeman, Gary
2011
7 4S p. S519-S520
2 p.
artikel
750 Development of ultra-sensitive assay for detection of aggregated beta amyloid in human CSF Scrocchi, Louise A.
2011
7 4S p. S145-
1 p.
artikel
751 Diabetes, impaired fasting glucose and 9 year decline among healthy older adults Yaffe, Kristine
2011
7 4S p. S691-S692
2 p.
artikel
752 Diagnostic Criteria of Apathy (DCA) and Neuropsychiatric Inventory-Clinician Scale (NPI-C) for the Assessment of Apathy in Clinical Practice: A Comparison Study David, Renaud
2011
7 4S p. S171-
1 p.
artikel
753 Diagnostic delay, medical and social pathways of early-onset Alzheimer's disease patients Paulin, Marion
2011
7 4S p. S625-
1 p.
artikel
754 Diagnostic utility of CSF biomarkers in an Alzheimer's clinic Snider, B. Joy
2011
7 4S p. S146-
1 p.
artikel
755 Diagnostic value of CSF biomarkers for (differential) dementia diagnosis Engelborghs, Sebastiaan
2011
7 4S p. S673-
1 p.
artikel
756 DIAN: MRI of familial Alzheimer's disease Fox, Nick
2011
7 4S p. S680-
1 p.
artikel
757 Dietary antioxidants and fat: Long-term risk of dementia and Cognitive Decline Devore, Elizabeth
2011
7 4S p. S485-S486
2 p.
artikel
758 Dietary factors and dementia Barberger-Gateau, Pascale
2011
7 4S p. S88-
1 p.
artikel
759 Dietary fatty acids (FA) and dementia: Observations from the Washington Heights and Inwood Columbia Aging Project Gustafson, Deborah
2011
7 4S p. S296-S297
2 p.
artikel
760 Dietary management of Alzheimer's disease by enhancing synapse formation: Rationale for the multi-nutrient approach with Fortasyn™ Connect Kamphuis, Patrick
2011
7 4S p. S653-S654
2 p.
artikel
761 Dietary nutrients and plasma β-amyloid Gu, Yian
2011
7 4S p. S502-S503
2 p.
artikel
762 Dietary patterns and cognitive functioning and change in community-dwelling older adults Danthiir, Vanessa
2011
7 4S p. e45-
1 p.
artikel
763 Diets associated with type 2 diabetes and insulin resistance affect CSF mediators of Beta-amyloid clearance and toxicity Craft, Suzanne
2011
7 4S p. S103-
1 p.
artikel
764 Differences in suicidal idea and behavior according to cognitive function in elderly people Bae, Jaenam
2011
7 4S p. S638-
1 p.
artikel
765 Different distribution of soluble beta-amyloid assemblies in the Tg2576 mouse brain and Alzheimer disease autopsy brain Bao, Fuxiang
2011
7 4S p. S380-S381
2 p.
artikel
766 Different effects of music therapy on language functions in vascular cognitive impairment associated with frontal glucose hypometabolism Akanuma, Kyoko
2011
7 4S p. S641-S642
2 p.
artikel
767 Different hierarchical cytoarchitectonic sub-type vulnerability to Aβ-deposits and gray matter loss in AD and MCI patients: A comparison between a young and old cohort Ng, Yen-Bee
2011
7 4S p. e37-e38
nvt p.
artikel
768 Differential association of memory endophenotypes to APOE alleles Pedraza, Otto
2011
7 4S p. S260-
1 p.
artikel
769 Differential contribution of soluble forms of α-synuclein, TDP-43 and PrPc to Alzheimer's disease-associated cognitive impairment Larson, Megan
2011
7 4S p. S389-
1 p.
artikel
770 Differential Epistatic Interactions with Alternative APOE Alleles in Late-Onset Alzheimer’s Disease Morgan, Kevin
2011
7 4S p. S190-S191
2 p.
artikel
771 Differential regulation of Abeta-40 and Abeta-42 extracellular levels by pattern of ongoing neuronal activity Dolev, Iftach
2011
7 4S p. S384-S385
2 p.
artikel
772 Differential regulation of the alternative splicing of tau exon 10 by protein kinase A isoforms Shi, Jianhua
2011
7 4S p. S560-
1 p.
artikel
773 Differentiating Alzheimer's disease from FTD: Do PIB, FDG, and MRI tell the same story? Chertkow, Howard
2011
7 4S p. S337-S338
2 p.
artikel
774 Differentiating Alzheimer's disease from FTD: Do PIB, FDG and MRI tell the same story? Chertkow, Howard
2011
7 4S p. S12-
1 p.
artikel
775 Differentiating normal from pathological brain aging (mild cognitive impairment and Alzheimer's disease) using standard neuropsychological tests Wakefield, Sarah
2011
7 4S p. S268-S269
2 p.
artikel
776 Different risk of dementia in mild cognitive impairment subtypes Serrano, Cecilia
2011
7 4S p. S534-
1 p.
artikel
777 Diffusion and morphometric MRI correlates of language function decline: A longitudinal study in dementia Frings, Lars
2011
7 4S p. S735-
1 p.
artikel
778 Diffusion tensor imaging and cognition in patients with subcortical vascular cognitive impairment Choi, Seong
2011
7 4S p. S752-
1 p.
artikel
779 Diffusion tensor imaging identifies hotspots of white matter damage in Alzheimer's disease O'Dwyer, Laurence
2011
7 4S p. S61-S62
2 p.
artikel
780 Diffusion tensor tractography of the corpus callosum in Alzheimer's Disease and frontotemporal dementia on 3 T MRI Gupta, Rohit
2011
7 4S p. S345-
1 p.
artikel
781 Dimebon (Latrepirdine) protects from cell death-induced by mitochondrial stressors and alpha-synuclein over-expression, and decreases alpha-synuclein protein levels in a Parkinson's disease cell model. Delgado, Luz
2011
7 4S p. S760-S761
2 p.
artikel
782 Direct angiotensin II type 2 receptor agonist, compound 21, improved cognitive function in mice with an increase in cerebral blood flow and an enhancement of excitatory post-synaptic potential Mogi, Masaki
2011
7 4S p. S658-S659
2 p.
artikel
783 Direct neuron to neuron transmission of β-amyloid oligomers causes neurodegeneration Nath, Sangeeta
2011
7 4S p. e2-
1 p.
artikel
784 Discovery and Replication of Gene-Gene Interactions in Multiple Independent Datasets from the Alzheimer Disease Genetics Consortium Thornton-Wells, Tricia
2011
7 4S p. S197-
1 p.
artikel
785 Discovery of novel [18F]-PET agents for imaging neurofibrillary tangles (NFTs) Kolb, Hartmuth
2011
7 4S p. e1-
1 p.
artikel
786 Discrepancies of memory functions in healthy and memory-impaired older persons Economou, Alexandra
2011
7 4S p. S275-S276
2 p.
artikel
787 Discrepancy between patient and proxy-rated pain in Alzheimer's' disease: Results from the Danish Alzheimer's intervention study (DAISY) Jensen-Dahm, Christina
2011
7 4S p. S630-
1 p.
artikel
788 Discriminating MCI subjects who will decline to Alzheimer's disease from controls: SVM versus medial temporal atrophy lobe rating Ahsan, R. Laila
2011
7 4S p. S19-
1 p.
artikel
789 Disrupted adult neurogenesis in a novel rat model of Alzheimer's disease Rezai-Zadeh, Kavon
2011
7 4S p. S505-
1 p.
artikel
790 Disrupted effective connectivity in the posterior cingulate is compensated by the temporo-parietal network in early Alzheimer's disease VanBoxtel, Martin
2011
7 4S p. S748-S749
2 p.
artikel
791 Disruption of mitochondrial transport promotes tau toxicity through Alzheimer's disease-related tau phosphorylation Iijima-Ando, Kanae
2011
7 4S p. S689-S690
2 p.
artikel
792 Dissecting pathogenic ApoE pathways with the ADNI dataset: The case for reelin Hemond, Christopher
2011
7 4S p. e28-
1 p.
artikel
793 Distinguish the visual top-down spatial attentional neural network between normal and dementia Ohta, Yasuyuki
2011
7 4S p. S231-
1 p.
artikel
794 Distribution of copy number variations in Alzheimer's disease Wang, Li-San
2011
7 4S p. S198-
1 p.
artikel
795 Divergence of effect analysis (slope analysis) in disease-modifying AD Trials Li, David
2011
7 4S p. S784-
1 p.
artikel
796 Do African Americans have the Same TOMM40 Distribution as Caucasians? Preliminary Results from Wisconsin Registry for Alzheimer’s Prevention (WRAP) Edwards, Dorothy
2011
7 4S p. S183-S184
2 p.
artikel
797 Does Alzheimer's disease over 80 years old have a different etiology? Kuller, Lewis
2011
7 4S p. S596-S597
2 p.
artikel
798 Does concomitant treatment with cholinesterase inhibitors or memantine affect cerebrolysin treatment's efficacy in Alzheimer disease? Results from the Argentinean cerebrolysin registry Previgliano, Ignacio
2011
7 4S p. S787-
1 p.
artikel
799 Does dementia affect the economic status of the oldest old? Results from the Monzino 80-plus Study Recchia, Angela
2011
7 4S p. S362-
1 p.
artikel
800 Does low dose ASA prevent cognitive decline in an elderly population at high cardiovascular risk? Kern, Silke
2011
7 4S p. S96-
1 p.
artikel
801 Does repeated daily testing improve measurement sensitivity to the cognitive effects of donepezil in mild to moderate Alzheimer's disease? Jaeger, Judith
2011
7 4S p. e59-
1 p.
artikel
802 Does reversible MCI exist? Chilovi, Barbara Vicini
2011
7 4S p. S548-
1 p.
artikel
803 Does the prevalence of dementia decrease? A comparison of two population-based samples of 85-year olds examined in 1986-1987 and 2008-2009 Skoog, Ingmar
2011
7 4S p. S510-
1 p.
artikel
804 Does Variation in Mitochondrial Haplogroups Associate with Alzheimer’s Disease? Sims, Rebecca
2011
7 4S p. S195-S196
2 p.
artikel
805 Dominantly inherited Alzheimer network clinical trials: A model for prevention trials Bateman, Randall
2011
7 4S p. S680-
1 p.
artikel
806 Dominantly Inherited Alzheimer Network (DIAN): History genetic and pathology overview and update Rossor, Martin
2011
7 4S p. S679-
1 p.
artikel
807 Dominantly inherited Alzheimer network (DIAN): Overview, aims and progress Morris, John
2011
7 4S p. S679-
1 p.
artikel
808 Donepezil causes acute increases in regional cerebral blood flow in normal rat Goodman, James
2011
7 4S p. S9-
1 p.
artikel
809 Donepezil causes acute increases in regional cerebral blood flow in normal rat Goodman, James
2011
7 4S p. S307-
1 p.
artikel
810 Donepezil decreases rate of hippocampal atrophy in patients with prodromal Alzheimer's disease Dubois, Bruno
2011
7 4S p. e17-
1 p.
artikel
811 Donepezil impairs memory in healthy older subjects: Behavioural, EEG and simultaneous EEG/fMRI biomarkers Balsters, Joshua
2011
7 4S p. S378-
1 p.
artikel
812 Do past and current depressive symptoms affect cognitive functioning and everyday activities in the elderly? Reppermund, Simone
2011
7 4S p. S261-S262
2 p.
artikel
813 Do standard anti-dementia drug trial tests capture symptoms that are important to patients with mild-moderate Alzheimer's disease and their carers? Rockwood, Kenneth
2011
7 4S p. S165-
1 p.
artikel
814 Double-Immune Challenge With The Viral Mimic Polyi:C Induces Alzheimer’s Disease-Like Neuropathology In Aged Wild-Type Mice Kneusel, Irene
2011
7 4S p. S286-
1 p.
artikel
815 Down-regulation of pin1 induces tau hyperphosphorylation through active GSK3β in rats and HEK293 cell Wang, Jian-Zhi
2011
7 4S p. S585-S586
2 p.
artikel
816 3-D reconstruction of CT Images by LabVIEW Jogdand, Pravin
2011
7 4S p. S42-
1 p.
artikel
817 Drosophila amyloid precursor protein (app) central nervous system confolal microscopy western assays 2011
7 4S p. S114-
1 p.
artikel
818 D-Serine synthesis and metabolism in the Alzheimer's brain Katsouri, Loukia
2011
7 4S p. S702-
1 p.
artikel
819 3-D structure of the transmembrane c-terminal domain of the amyloid precursor protein (C99), the immediate precursor of amyloid-β Barrett, Paul
2011
7 4S p. S381-
1 p.
artikel
820 DTI Quantitative study on medial temporal lobe of Alzheimer's disease Chen, Jung-Tai
2011
7 4S p. S732-S733
2 p.
artikel
821 Dual biomarker imaging with [11C]PIB and [18F]DG positron emission tomography in dementia Hüll, Michael
2011
7 4S p. S717-S718
2 p.
artikel
822 Dual-task performance and neurocognitive functions in older adults with and without amnestic mild cognitive impairment Makizako, Hyuma
2011
7 4S p. S614-
1 p.
artikel
823 Dynamic biomarker model in Alzheimer's disease: Testing the sigmoid hypothesis using ADNI Data Abderazzak, Mouiha
2011
7 4S p. S336-
1 p.
artikel
824 Dynamic of beta-amyloid deposition in healthy elderly, mild cognitive impairment and alzheimer's disease: a PiB-PET longitudinal study Villain, Nicolas
2011
7 4S p. S6-
1 p.
artikel
825 Dynamic of Beta-amyloid deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a PiB-PET longitudinal study Villain, Nicolas
2011
7 4S p. S226-S227
2 p.
artikel
826 Dynamic self-referent cognitive process on new learning is relatively preserved in Alzheimer's disease Lalanne, Jennifer
2011
7 4S p. S251-
1 p.
artikel
827 Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer's disease Ryu, Seon-Young
2011
7 4S p. S222-
1 p.
artikel
828 Dynein dysfunction causes the disturbance of synaptic vesicle transport and axonal swelling Kimura, Nobuyuki
2011
7 4S p. S587-
1 p.
artikel
829 Dysexecutive syndrome in subjective cognitive impairment Sambuchi, Nathalie
2011
7 4S p. S263-S264
2 p.
artikel
830 Dyslipidemia is a modifiable risk factor for cardiovascular and Alzheimer's diseases Allouche, Ahmad
2011
7 4S p. S607-S608
2 p.
artikel
831 Early accumulation of C99 in 3xTg mice Pardossi-Piquard, Raphaëlle
2011
7 4S p. S568-
1 p.
artikel
832 Early and chronic treatment with dantrolene blocked later learning and memory deficits in older Alzheimer's triple transgenic mice Peng, Jun
2011
7 4S p. e67-
1 p.
artikel
833 Early changes of cholinergic receptors in hippocampus and parietotemporal cortex of the rat model of sporadic Alzheimer's disease Knezovic, Ana
2011
7 4S p. S123-
1 p.
artikel
834 Early cognitive impairment sex difference in treated hypertensive patients Tarnovska-Kadreva, Rumiana
2011
7 4S p. S622-
1 p.
artikel
835 Early detection of MCI: Is the MoCA more sensitive for cognitive decline than the MMSE (a pilot study) Dierckx, Eva
2011
7 4S p. S536-
1 p.
artikel
836 Early detection of patients with mild cognitive impairment and Alzheimer's disease using a novel tactile approach Yang, Jiajia
2011
7 4S p. S270-
1 p.
artikel
837 Early diagnosis of Alzheimer's disease Charvin, Heidi
2011
7 4S p. S266-
1 p.
artikel
838 Early indicators of dementia risks: ESTS of cognition and achievement among the 1960 project talent high school cohort McNally, James
2011
7 4S p. S441-
1 p.
artikel
839 Early intervention with docosahexanoic Acid (DHA) protects APOE4 acceleration of cognitive decline and plasma biomarkers in APOE4/5xFAD mice Cole, Greg
2011
7 4S p. S503-
1 p.
artikel
840 Early-life ibuprofen treatment prevents and reverses memory deficits without altering beta-amyloid production or epileptiform cortical activity in the APP-PS1 model of AD Colas, Damien
2011
7 4S p. e9-
1 p.
artikel
841 Early-onset Alzheimer's disease is associated with a distinct neuropsychological profile Smits, Lieke
2011
7 4S p. S266-
1 p.
artikel
842 Early-onset Alzheimer's disease likely has autosomal recessive causes Wingo, Thomas
2011
7 4S p. e31-e32
nvt p.
artikel
843 Early-onset Alzheimer's disease patients show distinct changes in oscillatory brain dynamics de Waal, Hanneke
2011
7 4S p. S134-
1 p.
artikel
844 Early-onset versus late-onset Alzheimer's disease: A role for APOE e4? Van der Flier, Wiesje
2011
7 4S p. S89-
1 p.
artikel
845 Early-stage dyadic intervention for people with dementia and their partners Whitlatch, Carol
2011
7 4S p. S279-
1 p.
artikel
846 Editorial Board 2011
7 4S p. A7-
1 p.
artikel
847 Education modulates white matter structural integrity in older healthy subjects: A Diffusion Tensor Imaging Study Connolly, Joanna
2011
7 4S p. S418-S419
2 p.
artikel
848 Education, occupation and late-life social engagement and their effects on cognitive change Marioni, Riccardo
2011
7 4S p. S510-S511
2 p.
artikel
849 EEG and mild cognitive impairment (MCI): Possible predictive value for progression to lewy body dementia Bifolchetti, Stefania
2011
7 4S p. S551-
1 p.
artikel
850 EEG Coherence and Probabilistic Neural Networks for Classification of Alzheimer’s Disease Sankari, Ziad
2011
7 4S p. S175-S176
2 p.
artikel
851 EEG-derived biomarkers of normal age-related change in episodic memory Kilborn, Kerry
2011
7 4S p. S68-
1 p.
artikel
852 EEG-derived biomarkers of normal age-related change in episodic memory Kilborn, Kerry
2011
7 4S p. S321-
1 p.
artikel
853 EEG effects of scopolamine in healthy subjects: A standardized low resolution brain electromagnetic tomography (sLORETA) study Soufflet, Laurent
2011
7 4S p. S726-
1 p.
artikel
854 Effectiveness and costs-effectiveness of post-diagnosis treatment in dementia coordinated by memory clinics in comparison to treatment coordinated by general practitioners Meeuwsen, Els
2011
7 4S p. e51-
1 p.
artikel
855 Effectiveness of multifactorial drug therapy in an Alzheimer's transgenic model Bruno, Martin
2011
7 4S p. S573-S574
2 p.
artikel
856 Effectiveness of remote assistance for people with dementia at home using reminiscence system and a schedule prompter Kuwahara, Noriaki
2011
7 4S p. S793-S794
2 p.
artikel
857 Effectiveness of time-limited support groups for people with early-stage Alzheimer's disease Logsdon, Rebecca
2011
7 4S p. S279-
1 p.
artikel
858 Effect of Amyloid-Beta load on cognition is modified by the APOE status in a population-based sample of cognitively normal older adults Kantarci, Kejal
2011
7 4S p. S49-S50
2 p.
artikel
859 Effect of Antibodies against beta secretase cleavage site on cerebral amyloid angiopathy Rakover, Idan
2011
7 4S p. S471-
1 p.
artikel
860 Effect of apoaequorin on cognitive function Underwood, Mark
2011
7 4S p. e65-
1 p.
artikel
861 Effect of APOE genotype on hippocampal mitochondria in response to a mild ischemic challenge Searcy, James
2011
7 4S p. S528-
1 p.
artikel
862 Effect of APOE on rate of change in PIB retention across the cognitive continuum Wiste, Heather
2011
7 4S p. S332-
1 p.
artikel
863 Effect of APOE on rate of change in PIB retention across the cognitive continuum Wiste, Heather
2011
7 4S p. S38-S39
2 p.
artikel
864 Effect of Apolipoprotein E on cortical thickness and resting-state brain function in Alzheimer's disease Wang, Xiao
2011
7 4S p. S237-
1 p.
artikel
865 Effect of cerebrospinal fluid in Alzheimer's patients on amyloid β-protein oligomerization Ikeda, Tokuhei
2011
7 4S p. S387-
1 p.
artikel
866 Effect of cholesterol increase on APP-Bace1 clustering in lipid rafts and APP dimerization Marquer, Catherine
2011
7 4S p. S390-
1 p.
artikel
867 Effect of CSF collection procedures via cisterna magna catheter or lumbar puncture at different frequencies on Alzheimer's biomarker levels in cynomolgus monkeys Li, Jinhe
2011
7 4S p. S141-
1 p.
artikel
868 Effect of culture and language in the adaptation of the Montreal Cognitive Assessment (MoCA) in the Philippines Dominguez, Jacqueline
2011
7 4S p. S450-
1 p.
artikel
869 Effect of dementia patient memory and behavioral problems on physical health in African American and Caucasian caregivers Clay, Olivio
2011
7 4S p. S429-
1 p.
artikel
870 Effect of different estrogens on BACE in Alzheimer's disease Li, Rena
2011
7 4S p. S464-S465
2 p.
artikel
871 Effect of 6 months of monotherapy with the 5HT6 receptor antagonist SB-742457 or donepezil in subjects with mild-to-moderate Alzheimer's disease Maher-Edwards, Gareth
2011
7 4S p. S298-
1 p.
artikel
872 Effect of P165 peptide on production and differentiation of cultured embryo hippocampal Neural stem cells Originated from SD rats Zhang, Jingyan
2011
7 4S p. S467-
1 p.
artikel
873 Effect of strain background on pathology progression in tau mouse model Bailey, Rachel
2011
7 4S p. S515-S516
2 p.
artikel
874 Effect of tetrahydroxystilbene glucoside on MAPKs signal transduction pathway in APP transgenic model of Alzheimer's disease Zhang, Lan
2011
7 4S p. S668-S669
2 p.
artikel
875 Effect of TTR ligands on its ability to proteolytically process A-Beta peptide- insights from an A-Beta-derived fluorogenic substrate Ribeiro, Carlos
2011
7 4S p. S471-
1 p.
artikel
876 Effect of various cognitive enhancers in acquisition task of radial maze Jayarajan, Pradeep
2011
7 4S p. S119-
1 p.
artikel
877 Effects of a multidimensional program for family caregivers of persons with dementia in Korea Park, Myonghwa
2011
7 4S p. S433-
1 p.
artikel
878 Effects of amyloid-beta and human amylin on mitochondrial function and estradiol production Grimm, Amandine
2011
7 4S p. S386-
1 p.
artikel
879 Effects of amyloid (1-42) peptide on cortical neuron/glia cultures from parkin null mice. Role of autophagy and glutathione homeostasis Solano, Rosa
2011
7 4S p. S523-
1 p.
artikel
880 Effects of Apolipoprotein E Allele and Age in Alzheimer’s Disease and Mild Cognitive Impairment in a Memory Clinic Cohort in Beijing Wang, Xiao
2011
7 4S p. S169-
1 p.
artikel
881 Effects of cannabinoids on the short and long-term memory functions in mice Avdesh, Avdesh
2011
7 4S p. S120-S121
2 p.
artikel
882 Effects of dependency level of the elderly on the quality of life in Depok, Indonesia Ratna, Lidwina
2011
7 4S p. e52-e53
nvt p.
artikel
883 Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice Corona, Carlo
2011
7 4S p. S457-S458
2 p.
artikel
884 Effects of estrogen in a friedreich's ataxia disease model Richardson, Timothy
2011
7 4S p. e63-
1 p.
artikel
885 Effects of extended-release memantine (28 mg/day) on activities of daily living in patients with moderate to severe alzheimer's disease: Post hoc factor analysis of a randomized trial Tocco, Michael
2011
7 4S p. S790-S791
2 p.
artikel
886 Effects of extended-release memantine (28 mg/day) on cognitive domains in patients with moderate to severe Alzheimer's disease: Post hoc analysis of a randomized trial Tocco, Michael
2011
7 4S p. S784-S785
2 p.
artikel
887 Effects of human intravenous immunoglobulins on amyloid pathology and inflammation in a mouse model of Alzheimer's disease Puli, Lakshman
2011
7 4S p. S694-
1 p.
artikel
888 Effects of 6-month monotherapy treatment with the 5HT6 receptor antagonist SB 742457 or donepezil in subjects with mild-to-moderate Alzheimer's disease Maher-Edwards, Gareth
2011
7 4S p. S777-S778
2 p.
artikel
889 Effects of MRI markers of cerebrovascular disease on amyloid burden and cognition in aging Marchant, Natalie
2011
7 4S p. S422-
1 p.
artikel
890 Effects of music therapy on anxiety and depression in patients with Alzheimer's disease: A randomized controlled trial Guetin, Stephane
2011
7 4S p. e49-
1 p.
artikel
891 Effects of n-3 fatty acids on cognitive decline: A randomized double-blind, placebo-controlled trial in stable myocardial infarction patients Geleijnse, Johanna
2011
7 4S p. S512-
1 p.
artikel
892 Effects of Nogo-66 receptor on both neuronal neurite regeneration and amyloid-β protein production Xiao, Fei
2011
7 4S p. S657-S658
2 p.
artikel
893 Effects of specific lipid-based diets on behavior, cognition, cerebral metabolism and hemodynamics, and inflammatory markers in APP/PS1, ApoE4 and ApoE knockout mice Jansen, Diane
2011
7 4S p. S650-
1 p.
artikel
894 Effects of specific nicotinic acetylcholine receptor agonists on hippocampal long-term potentiation Rosenbrock, Holger
2011
7 4S p. S116-
1 p.
artikel
895 Effects of surgery on cortical atrophy Kline, Richard
2011
7 4S p. S3-
1 p.
artikel
896 Effects of the Apolipoprotein E genotype on memory performance and brain morphology in young healthy adults Hampel, Harald
2011
7 4S p. S233-
1 p.
artikel
897 Effects of vitamin D deficiency in cognition in a nursing home in Puerto Rico Marti, Melisa Martinez
2011
7 4S p. S597-S598
2 p.
artikel
898 Effects of ZC plus hormone treatment on a transgenic mouse model of Alzheimer's disease Mendoza, Kriscelle
2011
7 4S p. S467-
1 p.
artikel
899 Efficacy and safety of an herbal therapy in patients with early stage of Alzheimer's disease: A 24-week randomized phase III trial Tian, Jinzhou
2011
7 4S p. S790-
1 p.
artikel
900 Efficacy and safety of florbetaben for beta-amyloid brain positron emission tomography in Alzheimer's disease: Results from a global phase IIb trial Osama, Sabri
2011
7 4S p. S696-S697
2 p.
artikel
901 Efficacy and safety of systemic versus intracerebroventricular delivery of a β-secretase (BACE1) small molecule inhibitor in a mouse model of Alzheimer's disease Thakker, Deepak
2011
7 4S p. S474-
1 p.
artikel
902 Efficacy and tolerability of two galantamine titration regimens in patients switched from donepezil Richarz, Ute
2011
7 4S p. S800-
1 p.
artikel
903 Efficacy of a novel, orally active GSK-3 Inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice Uno, Yumiko
2011
7 4S p. S483-
1 p.
artikel
904 Efficacy of a nutriceutical formulation on cognitive performance and function in MCI and Alzheimer's disease Shea, Thomas
2011
7 4S p. S788-S789
2 p.
artikel
905 Efficacy of high-dose, extended-release memantine (28 mg, once daily): Post hoc responder analysis from a randomized trial in patients with moderate to severe Alzheimer's disease Graham, Stephen
2011
7 4S p. S782-
1 p.
artikel
906 Efficacy of Memantine in delaying clinical worsening: Responder analyses in patients with moderate to severe Alzheimer's disease Hellweg, Rainer
2011
7 4S p. S782-
1 p.
artikel
907 Efficacy of memantine in patients with Alzheimer's disease: Meta-analyses of 9 clinical trials Rüther, Eckart
2011
7 4S p. S783-
1 p.
artikel
908 Efficacy of the cognitive activation therapy (CAT) in Alzheimer's disease during six month period Gollin, Donata
2011
7 4S p. S448-
1 p.
artikel
909 Efficiency of memantine - a meta-analysis of non-interventional studies in the treatment of Alzheimer's disease Riepe, Matthias
2011
7 4S p. S787-S788
2 p.
artikel
910 Egr1 binding and histone modification mapping in brain of mouse model of AD Lefterov, Iliya
2011
7 4S p. S703-S704
2 p.
artikel
911 Elderly driving laws and associated crash risk: Analysis of state level data in the USA Gupta, Apar
2011
7 4S p. S640-
1 p.
artikel
912 Elevated cerebrospinal fluid amyloid-Beta42 levels in young adults at genetic risk for early-onset alzheimer's disease Reiman, Eric
2011
7 4S p. S102-S103
2 p.
artikel
913 Elevated glutamate transport by GLT1 attenuates inflammation-induced memory impairment Brothers, Holly
2011
7 4S p. S650-
1 p.
artikel
914 Elevated levels of soluble, high molecular weight SDS-denaturable Aβ-aggregates are associated with dendritic degeneration in APP-transgenic mouse models Upadhaya, Ajeet Rijal
2011
7 4S p. S569-S570
2 p.
artikel
915 Elevation of inflammatory markers precedes development of neuroinflammatory pathology and neuronal loss in mice expressing constitutively active c-Abl in forebrain Schlatterer, Sarah
2011
7 4S p. S527-
1 p.
artikel
916 Elimination of APP caspase cleavage site D664 attenuates Aβ-mediated synaptic depression Midthune, Brea
2011
7 4S p. S588-
1 p.
artikel
917 Elucidating the anti-oxidant function of apoD: Relevance to Alzheimer's disease Bhatia, Surabhi
2011
7 4S p. S574-
1 p.
artikel
918 Empathy and frontal behavioral patterns discriminate between vascular dementia, Alzheimer's disease and frontotemporal dementia Alladi, Suvarna
2011
7 4S p. e43-e44
nvt p.
artikel
919 Empirically derived mild cognitive impairment subtypes based on performance on memory tests predict conversion to Alzheimer's disease Dowling, Maritza
2011
7 4S p. S242-
1 p.
artikel
920 End-of-life and finitude in severe dementia: View of family and physician Topciu, Flavia
2011
7 4S p. e52-
1 p.
artikel
921 Endolysosome involvement in LDL cholesterol-induced Alzheimer's disease-like pathology in primary cultured neurons Geiger, Jonathan
2011
7 4S p. S405-
1 p.
artikel
922 Endovascular low-energy laser radiation effect on dyscirculatory angiopathy of Alzheimer's type in the treatment of Alzheimer's disease Maksimovich, Ivan
2011
7 4S p. S791-S793
3 p.
artikel
923 Enhanced amyloidogenic processing of APP in alcadeina-deficient mice Gotoh, Naoya
2011
7 4S p. S565-
1 p.
artikel
924 Enhanced muscarinic receptor responses in vitro after multi-nutrient supplementation Savelkoul, Paul
2011
7 4S p. S655-
1 p.
artikel
925 Enhanced risk of mild cognitive impairment and its progression to dementia among APOE ϵ4 carriers Xu, Weili
2011
7 4S p. S369-
1 p.
artikel
926 Enhancing mitochondrial function with the ketones acetoacetate and β-hydroxybutyrate alleviates soluble Aβ42 toxicity Maalouf, Marwan
2011
7 4S p. S798-
1 p.
artikel
927 Enhancing verbal fluency in healthy older adults Hohaus, Lydia
2011
7 4S p. S611-
1 p.
artikel
928 Enriched Rater Training and In-Study Ratings Surveillance: A Synergy? Miller, David
2011
7 4S p. S176-S177
2 p.
artikel
929 ENU mutagenesis screening to identify novel regulators of tau-associated toxicity Liu, Xin
2011
7 4S p. S522-
1 p.
artikel
930 Environmental enrichment modulates Alzheimer's disease pathology via AKT/GSK3ß dependent pathway Jennifer Hu, Yuan-Shih
2011
7 4S p. e60-e61
nvt p.
artikel
931 Environmental enrichment paradigm in APP23 Albani, Diego
2011
7 4S p. S525-
1 p.
artikel
932 Epidemiological studies of abeta levels Reitz, Christiane
2011
7 4S p. S485-
1 p.
artikel
933 Epidemiologic and neuropsychological difference between urban community and hospital dementia patients Kim, Taewan
2011
7 4S p. S627-
1 p.
artikel
934 Epigenetic effects of Aβ and the implication on the pathophysiology in Alzheimer's disease Lithner, Christina Unger
2011
7 4S p. S508-
1 p.
artikel
935 Epigenetic mechanisms involving Aβ production in SH-SY5Y cells treated with anisomycin Li, Liang
2011
7 4S p. S402-
1 p.
artikel
936 Epigenetic regulation of tau gene expression Meredith, Gavin
2011
7 4S p. S509-
1 p.
artikel
937 Episodic long-term memory as a predictor of change from retrieval to storage memory profile in amnestic mild cognitive impairment Rodriguez-Noriega, Emma
2011
7 4S p. S262-
1 p.
artikel
938 Episodic memory decline is associated with cortical amyloid accumulation in healthy community-dwelling, non demented older adults Darby, David
2011
7 4S p. S682-
1 p.
artikel
939 ERP as a biomarker for Alzheimer's disease: The cognision system Casey, David Allan
2011
7 4S p. S132-
1 p.
artikel
940 ER stress: an initiator of neuroinflammation in Alzheimer's disease? Ayasolla, Kameshwar
2011
7 4S p. S413-
1 p.
artikel
941 Establishment of a functional assay for studying allosteric modulation of M1 muscarinic acetylcholine receptors in mouse primary cortical neurons Sand, Astrid
2011
7 4S p. S664-
1 p.
artikel
942 Estimating the impact of differences among protocols for manual hippocampal segmentation on Alzheimer's disease-related atrophy: Preparatory phase for a harmonized protocol Boccardi, Marina
2011
7 4S p. S7-S8
2 p.
artikel
943 Estimating the impact of differences among protocols for manual hippocampal segmentation on Alzheimer's disease-related atrophy: Preparatory phase for a harmonized protocol Boccardi, Marina
2011
7 4S p. e34-
1 p.
artikel
944 Estimating the impact of differences among protocols for manual hippocampal segmentation on Alzheimer's disease-related atrophy: Preparatory phase for a harmonized protocol Boccardi, Marina
2011
7 4S p. S205-S206
2 p.
artikel
945 Estimating transitional probabilities to dementia and cognitive impairment Gao, Sujuan
2011
7 4S p. S510-
1 p.
artikel
946 Estimation of total intracranial volume; a comparison of methods Ridgway, Gerard
2011
7 4S p. S62-S63
2 p.
artikel
947 Estime study: Apathy and depression in mild and newly diagnosed Alzheimer disease Robert, Philippe
2011
7 4S p. S362-S363
2 p.
artikel
948 17α ± -estradiol inhibits oxidative stress, Aβ release, apoptosis, and changes in Ca2+ distribution in two in vitro models of Aβ pathology Drew, Amy
2011
7 4S p. S458-
1 p.
artikel
949 Estrogen receptor-alpha in the Alzheimer's disease brain Ishunina, Tatiana
2011
7 4S p. S685-S686
2 p.
artikel
950 Estrogen signaling prevents Abeta-induced defects in dendritic mitochondial structure and mobility Sarkar, Saumyendra
2011
7 4S p. S589-
1 p.
artikel
951 Ethanol effect over amyloid-beta aggregates and toxicity reduction in cell cultures In silico modulation of ultarstrucutural mechanism Parodi, Jorge
2011
7 4S p. S394-
1 p.
artikel
952 Ethics of Early Identification of Alzheimer's Disease Karlawish, Jason
2011
7 4S p. S82-
1 p.
artikel
953 Ethnic/Cultural differences in the incremental cost of health care services associated with Alzheimer's disease McCombs, Jeffrey
2011
7 4S p. S432-
1 p.
artikel
954 Ethnic Differences in Risk of Non-Fatal Stroke Occurring After Onset of Alzheimer’s Disease Whitmer, Rachel A.
2011
7 4S p. S169-
1 p.
artikel
955 Etiological aspects involved in cognitive decline in young adults Sterea, Alexandru
2011
7 4S p. S372-
1 p.
artikel
956 European diagnostic network of earliest Alzheimer's: New metabolic strategies for preclinical diagnostics and therapy of Alzheimer's disease Fedorova, Anna
2011
7 4S p. S620-
1 p.
artikel
957 EVADE study: Elopement evaluation on Alzheimer's disease patients in France Delabriere, Isabelle
2011
7 4S p. S623-
1 p.
artikel
958 Evaluating alpha-synuclein toxicity in a ubiquitin-impaired environment Rodrigues, Catia
2011
7 4S p. e48-
1 p.
artikel
959 Evaluating Epistatic Interactions in Alzheimer’s Disease Using Multifactor Dimensionality Reduction and Entropy-Based Estimation Huang, Ming-Shan
2011
7 4S p. S182-
1 p.
artikel
960 Evaluating semagacestat, a gamma-secretase inhibitor, in a phase III trial Siemers, Eric
2011
7 4S p. S484-S485
2 p.
artikel
961 Evaluation and modulation of toxic degenerative pathways induced by beta-amyloid on retinal cells: Role of P2X7 cell death receptor Rat, Patrice
2011
7 4S p. S379-S380
2 p.
artikel
962 Evaluation of a multidimensional cognitive training program for healthy older adults Wolf, Anna
2011
7 4S p. S269-S270
2 p.
artikel
963 Evaluation of benefits of a healing garden for Alzheimer patients: new methodology to evaluate a design concept integrating artistic and neuropsychological approaches Rivasseau Jonveaux, Therese
2011
7 4S p. S442-S443
2 p.
artikel
964 Evaluation of beta amyloid loss to CSF sample collection and storage containers Riordan, Henry
2011
7 4S p. S327-
1 p.
artikel
965 Evaluation of Cognitive Endophenotypes for Association with CLU, CR1 and PICALM LOAD Risk Genes Pedraza, Otto
2011
7 4S p. S191-S192
2 p.
artikel
966 Evaluation of color preference in zebrafish: A possible potential model for learning and memory disorders Avdesh, Avdesh
2011
7 4S p. S120-
1 p.
artikel
967 Evaluation of CSF Aβ40 with a new immunoassay Innotest β amyloid 1-40 prototype kit in Alzheimer's disease and apparented syndromes Ferrari, Patricia
2011
7 4S p. S335-
1 p.
artikel
968 Evaluation of CSF cystatin C, beta-2-microglobulin, and VGF as diagnostic biomarkers of Alzheimer's disease using SRM Ward, Malcolm A.
2011
7 4S p. S150-S151
2 p.
artikel
969 Evaluation of known Alzheimer's genes for SNPs that influence their brain expression (eSNPs) Allen, Mariet
2011
7 4S p. S498-
1 p.
artikel
970 Evaluation of neurodegeneration and cognitive decline in Alzheimer's disease by using combined techniques of non conventional MRI Giugni, Elisabetta
2011
7 4S p. S717-
1 p.
artikel
971 Evaluation of prevalence and treatment of neuropsychiatric symptoms in elderly patients with dementia: 9 year-follow-up Bozoglu, Ergun
2011
7 4S p. S239-
1 p.
artikel
972 Evaluation of retinoblastoma protein expression in asymptomatic and symptomatic Alzheimer's disease and normal elderly subjects Silva, Aderbal
2011
7 4S p. S706-S707
2 p.
artikel
973 Evaluation of serum biomarkers for cognitive impairment in centenarians Holcomb, Erin
2011
7 4S p. S248-
1 p.
artikel
974 Evaluation of the Creative Ways to Care: Strategies for Carers of People Living With Dementia Program Parker, Barbara
2011
7 4S p. S291-
1 p.
artikel
975 Evaluation of the efficacy and safety of florbetaben PET in adults with down syndrome Jennings, Danna
2011
7 4S p. S49-
1 p.
artikel
976 Evaluation of the plasma proteomics data from the ADNI database for Alzheimer's disease-state classification and prediction of 12-month progression from MCI to AD Devanarayan, Viswanath
2011
7 4S p. S545-
1 p.
artikel
977 Evaluation of the tau aggregation inhibitors and immunization with phosphorylated tau peptides in tauopathy model mice Suzukake, Masami
2011
7 4S p. S482-
1 p.
artikel
978 Evaluation of three hand position test of Luria in Alzheimer's disease and your relationship with age Herrera Jr., Emílio
2011
7 4S p. S247-
1 p.
artikel
979 Evaluation of translational Alzheimer's disease biomarkers in the aged dog: The effects of age and bace inhibition on CSF amyloid Araujo, Joseph A.
2011
7 4S p. S120-
1 p.
artikel
980 Event-related potentials predict persons at genetic risk for Alzheimer's disease Murphy, Claire
2011
7 4S p. S216-S217
2 p.
artikel
981 Evidence for neuronal compensation during episodic memory in subjective memory impairment Jessen, Frank
2011
7 4S p. S213-
1 p.
artikel
982 Evidence for the involvement of the RSG2 gene in risk for anxiety and related phenotypes in an elderly population not selected for this trait Lendon, Corinne
2011
7 4S p. e71-
1 p.
artikel
983 Evidence of Sleep Apnea in MCI/Mild Dementia Hannesdottir, Kristin
2011
7 4S p. S172-
1 p.
artikel
984 Evidence on the ability of molecular chaperones to bind and neutralize toxic protein oligomers and molecular insight into their mechanism of action Chiti, Fabrizio
2011
7 4S p. S694-
1 p.
artikel
985 Evidence that gamma-secretase inhibitors induce an incomplete processing phenotype in preclinical models Mercken, Marc
2011
7 4S p. S467-S468
2 p.
artikel
986 Evolution of fibrillar amyloid in relation to astro- and microgliosis and alterations in α7 nicotinic receptors in Alzheimer APPswe mice as studied with multi-tracer concept Thomé, Carina
2011
7 4S p. e16-e17
nvt p.
artikel
987 Examining CSF biomarkers and their ability to predict dementia, a systematic review of the literature Budd, David
2011
7 4S p. S314-
1 p.
artikel
988 Examining the role of c-jun n-terminal kinase on hypothermia-induced tau phosphorylation in cortical neurons and mouse brain Papworth, Jonathan
2011
7 4S p. S662-
1 p.
artikel
989 Excess acute care costs among U.S. Medicaid Alzheimer's patients in the year prior to diagnosis Geldmacher, David
2011
7 4S p. e2-
1 p.
artikel
990 Excessive TV watching in patients with frontotemporal dementia Shin, Ji Soo
2011
7 4S p. e52-
1 p.
artikel
991 Excitotoxicity in Alzheimer's disease or network dys function in Alzheimer's disease Mucke, Lennart
2011
7 4S p. S86-
1 p.
artikel
992 Executive performance and motor control in a cohort of oldest-old: The PIETÀ study Machado, Thais
2011
7 4S p. S255-
1 p.
artikel
993 Exercise, Cognition and the Brain Kramer, Arthur
2011
7 4S p. S87-
1 p.
artikel
994 Exercise, Cognition and the Brain Kramer, Arthur
2011
7 4S p. S87-
1 p.
artikel
995 Existing data support wild-type mouse is a suitable preclinical model for predicting human CSF abeta efficacy of gamma secreatase inhibitors Zhang, Liming
2011
7 4S p. S531-
1 p.
artikel
996 Exogenous advanced glycation end products induce tau hyperphosphorylation and spatial memory deficit through RAGE-mediated Akt/GSK-β pathway Zhou, Xin-Wen
2011
7 4S p. S401-
1 p.
artikel
997 Exosomes in the release and transcellular spread of amyloid: Implications for Neurodegenerative diseases Rajendran, Lawrence
2011
7 4S p. S106-
1 p.
artikel
998 EXPECT (EXelon Patch EffeCtiveness Trial): Effectiveness and tolerability of transdermal rivastigmin in daily practice Articus, Konstantin
2011
7 4S p. S777-
1 p.
artikel
999 Experiences of adverse life events and risk of dementia: A 38-Year longitudinal population study of women Johansson, Lena
2011
7 4S p. S692-S693
2 p.
artikel
1000 Exploiting the diversity of the chaperone repertoire to treat tauopathies Jinwal, Umesh
2011
7 4S p. S554-
1 p.
artikel
                             2578 gevonden resultaten
 
   volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland